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Abstract
In this thesis, the HT-22 mouse hippocampal cell line model, which is characterised by 
lack of glutamate receptors, was used to elucidate the mechanism of the glutamate- 
induced cell death mechanism through the glutamate receptor-independent pathway.
It is shown that the HT-22 cells die tlirough a form of programmed cell death that shares 
features of both classical apoptosis and necrosis. Inhibition of the kinase activity of 
receptor interacting protein 1 (RIP-1) by Necrostatin-1 inhibited glutamate-induced cell 
death, suggesting that glutamate-induced HT-22 cell death occurred through 
necroptosis.
Glutamate induced an increase in reactive oxygen species (ROS) levels in HT-22 cells 
which originated primarily from the mitochondria. Glutamate also caused a dose- 
dependent decrease in mitochondrial membrane potential (A¥m) which was correlated 
ROS levels in the cells. Under these conditions of oxidative stress induced by glutamate, 
mitochondrial permeability transition (MPT) occurred through opening of the MPT 
pores, which in turn lead to AYm collapse and ultimately contributed to glutamate- 
induced cell death.
Cell cycle analysis revealed that cell division in HT-22 cells was intimately linlced to the 
process of cell death. L-glutamate treatment of HT-22 cells did not affect the cell cycle. 
However, the role of cell cycle in glutamate-induced HT-22 cell death pathway was 
shown through arresting the cell cycle at specific points. Cell cycle arrest protected the 
cells from glutamate-induced cell death. Further confirmation that re-entry to the cell 
cycle is involved in glutamate-induced cell death came fi'om the observation that 
glutamate only caused cell death once the cycle was allowed to progress by removal of 
the inhibitory conditions.
In conclusion, the work presented in this thesis shows that glutamate-induced oxidative 
cell injury involves the formation of ROS and mitochondrial damage. However, cell 
death depends on the ability of the cells to progiess through the cell cycle past mitosis.
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1 Introduction
C h a p t e r  1 :  In t r o d u c t i o n
1.1 Neuronal injury
Mature neurons are among the most long-lived cell types, but they are not replaceable 
because they are terminally differentiated. Thus, brain ageing is characterised by a slow 
and irreversible loss of neurons. In addition, the loss of neuronal cells due to trauma, 
stroke, or ischaemia or other neuronal conditions leads to both acute and chronic 
neurodegenerative diseases such as Alzheimer’s and Parkinson's disease. The 
mechanisms of cell death and the intracellular pathways responsible for translating the 
signals into cell-death programs are still under investigation. Excitotoxicity is thought to 
be a major contributor to ischaemic neuronal cell death via excessive release and 
activation of glutamate receptors. Immature neurons may be characterised by a lack of 
glutamate receptors and are therefore resistant to excitotoxic mediated cell death. 
However, an alternative non-glutamate receptor-mediated oxidative neurotoxic pathway 
has also been described in immature primary neurons and in oligodendroglia (Murphy 
and Baraban, 1990, Yoshioka et a/., 2000).
In vitro studies in the HT-22 mouse hippocampal cell line that is characterised by lack 
of glutamate receptors, HT4 cells that are not sensitive to excitotoxicity, or using 
glutamate receptor blocking techniques, have all confirmed the existence of non­
glutamate receptor-mediated cell death (Gwag et al ,  1995, Newell et al ,  1995, Tan et 
al,  1998b, Tirosh et al ,  2000). In these studies, glutamate-receptor independent neurons 
have been described to be resistant to excitotoxicity but were nevertheless killed by L- 
glutamate thiough inliibition of a cystine / glutamate exchanger. The consequent 
reduction in cysteine levels, a precursor amino acid required for the tripeptide
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glutathione is thought to then render cells susceptible to reactive oxygen species (ROS)- 
induced damage, ultimately leading to oxidative cell death (Tan et al ,  1998b, Tirosh et 
al,  2000).
1.1.1 Glutamate-induced neuronal injury pathways
Glutamate is a proteinogenic amino acid and is considered a principal excitatory amino 
acid that acts as a neurotransmitter in the mammalian nervous system. Glutamate is 
known to be involved in cognitive functions like learning and memory (Hediger and 
Welboume, 1999, Mark et al ,  2001). However, in order to avoid constant neuronal 
excitation, low steady-state concenti'ations of glutamate are maintained by excitatory 
amino acid Transporters (EAAT) that function to clear excessive amounts of glutamate 
from the neuronal extracellular space and participate in the re-uptake of synaptically 
released glutamate (Hediger and Welbourne, 1999). Glutamate over-release can be 
attributed to cerebral ischaemic, traumatic brain injuiy or stroke. Excessive glutamate 
concentrations have been reported in neurodegenerative disorders, such as amyotrophic 
lateral sclerosis (ALS) (Spreux-Varoquaux et al ,  2002), Huntington’s disease, 
Parkinson’s disease and Alzheimer’s disease (Bergmann and Keller, 2004). Many cases 
of glutamate-induced neuronal cells death dfrectly involve glutamate receptor excitation, 
however as mentioned above, another mechanism involves disregulation of a 
glutamate/cystine exchanger (Muiphy and Baraban, 1990).
1.1.2 Glutamate-induced excitotoxicity in neuronal cell death
Excitatory glutamate acts mainly on two basic types of neuronal receptors: ionoti'opic 
and metabotropic receptors. lonotropic glutamate receptors are directly coupled to
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membrane ion channels and are divided into three subtypes of receptors: I) N-methyl D- 
aspartate (NMDA), II) a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) and III) kainate receptors (Kline and Tsao, 2008, Mark et al ,  2001). 
Metabotropic receptors can be divided into three main gi'oups: Group I (mGlul and 
niGlu5), Group II (mGlu2 and mGlu3), and Group III (niGlu4, mGlu6, niGlu7, and 
mGlu8) (Kline and Tsao, 2008, Mark et al ,  2001), Receptor-initiated glutamate toxicity 
occurs as a result of over activation of the ionotrophic receptors, particularly the NMDA 
receptor. Excitotoxic pathways are related mainly to the excessive influx of ions, 
particularly Ca^ "^ ’ where NMDA is the most Ca^ "^  permeable glutamate receptor (Colwell 
and Levine, 1999, Li et al ,  2009, Limbrick et al ,  2001, Limbrick et al ,  2003).
Activation of NMDA receptors results in the opening of an ion channel that is non- 
selective to cations and allows Ca^ "^  ions to flow into the cell (Chong et al,  2005, 
Limbrick et al ,  2003). Calcium influx leads to the activation of a number of enzymes 
such as phosphatases and phospholipases proteases, nitric oxide synthases or 
endonucleases that eventually lead to neuronal cell death. Moreover, increased 
intracellular Ca^ "^  activates nitric oxide synthase (NOS) and consequently increases 
nitric oxide (NO) levels (Emerit et al ,  2004). Protease activation plays an important role 
in the production of free radicals, for example by cleaving xanthine dehydrogenase into 
xanthine oxidase, an important enzyme in the production of superoxide and -hydroxyl 
free radicals. Activation of proteases such as calpains, due to excessive calcium entry 
also ti'iggers programmed cell death of neurons (Chard et al ,  1995, Monnerie and Le 
Roux, 2008). In addition, the imbalance of calcium haemostasis leads to mitochondrial
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damage causing further increases in ROS, the loss of mitochondrial membrane potential, 
and potentially the release cytochrome C that initiates the apoptosis cascade (Chi et al., 
2008, Hansson et al ,  2008, Mathisen et al ,  2007).
1.1.3 Glutamate-induced receptor-independent neuronal cell death 
Although glutamate-induced neurotoxicity has been attributed to glutamate receptors, 
several human clinical hials employing glutamate receptor antagonists have failed to 
protect patients against neuron injury (Greene and Greenamyre, 1995, Gwag et al,  
1995). In addition, immature neurons that are characterised by a lack of functional 
glutamate receptors have failed to survive in the presence of excessive glutamate 
concentrations (Gwag et al., 1995, Murphy and Baraban, 1990, Newell et al,  1995). 
Therefore, additional mechanisms of excitotoxicity have been suggested including 
glutamate-induced oxidative neurotoxicity via a receptor independent pathway (Elphick 
et al ,  2008, Tan et al ,  1998b). Reactive oxygen species (ROS) are an important feature 
during receptor-independent glutamate toxicity (Atlante et al. 2001;Elphick et al  2008). 
High levels of extracellular glutamate limit or even reverse of the cystine/ glutamate 
exchanger and results in lower cystine uptake into cells (Tan et al ,  1998a).
The cystine/ glutamate exchanger, or the so-called Xc transporter consists of the two 
subunits xCT and 4F2 and has been found in numerous types of mammalian cells 
(Bannai, 1986). It mediates the sodium-independent exchange of cystine and glutamate 
at the plasma membrane. Typically, the cystine/ glutamate exchanger promotes the 
cellular uptake of cystine thiough the efflux of glutamate. Intracellular cystine is 
reduced to cysteine, which may then be incorporated into the key intracellular
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anti oxidant molecule, glutathione (GSH) (Bannai, 1986, Halliwell and Gutteridge, 
1991). Even though cysteine is not an essential amino acid, most cells die in its absence 
because cysteine is a critical component of GSH. GSH is the predominant mechanism 
for the reduction of H2O2 and lipid hydroperoxides and is capable of conjugating non- 
enzymatically to highly reactive electrophilic compounds, to reduce their reactivity and 
make them easier to excrete.
GSH is located mainly in the cytosol and nucleus and accounts for more than 90% of 
cellular non-protein thiols (Deneke and Fanburg, 1989). However, the remainder of 
cellular GSH (10-15%) is located in the mitochondria and is considered significant for 
protecting the organelle firom ROS produced during coupled mitochondrial electron 
transport and oxidative phosphorylation (Reed, 1990). GSH is also important for many 
cellular biochemical functions including the regulation of gene transcription and the 
modulation of apoptosis (Cheng et al ,  2008). Therefore, in the absence of ionotrophic 
glutamate receptor excitation, glutamate can cause receptor-independent neuronal cell 
death via disrupting the concentrations of cysteine available for use in GSH. In this case, 
glutamate-induced oxidative injury and the death of neuronal cells have been clearly 
attributed to lack of GSH and other major intracellular antioxidant depletion.
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Neurons are irreplaceable, terminally differentiated cells. Therefore, under basal 
conditions they are not subject to cell death processes unless they are exposed to stress 
or cell death signalling. Under certain conditions, such as ischaemia or stroke, neurons 
are subject to the same basic molecular process that leads to cell death and 
neurodegenerative diseases. Cell death patterns can be categorised depending on cell’s 
ultra-stmctural moiphological features (Figure 1.1), in addition to the cascade of events 
that lead to cell death at the molecular level, such as cytoclii'ome C release, caspase 
activation, and other biochemical events. The basic cell death types are apoptosis, 
autophagy, and necrosis. However, in recent years many different subtypes of neuronal 
cell death have been described to be involved in neurodegenerative diseases.
Sub-types of neuronal cell death include apoptosis-like programmed cell death (Lang- 
Roilin et ah, 2003, Ziv et al ,  1994), necrosis-like progiammed cell death (Sée and 
Loeffler, 2001), and necroptosis (Li et al ,  2008). The type of cell death that neurons 
undergo depends on the insult intensity and the degree of injuiy, e.g. following 
ischaemia the neurons undergo necrotic cell death in the core of the lesion, where most 
of the cells suffer severe hypoxia, while apoptosis occurs in the area where blood flow 
reduces the severity of hypoxia insults (Chamaut-Marlangue et al ,  1996, Linnik et al ,  
1993). Therefore, understanding and defining neuronal cell death type is important when 
attempting to rescue neurons following injuiy.
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F igu rel.l Morphological feature of cell death
Electron microscopy images show the morphological features o f (a) normal, (b) autophagic, (c) apoptotic, 
(d) and necrotic cells (figure taken from Edinger and Thomson 2004). Autophagic cells can be 
distinguished by the presence o f autophagosomes while apoptotic cells show chromatin condensation and 
outer membrane integrity. Necrotic cells show dilation o f intracellular organelles and are associated 
with loss o f membrane integrity.
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1.2.1 Apoptosis
Apoptosis is a well-characterised mechanism of neuronal cell death, first described by 
Kerr, Wyllie, and Cume (KeiT et al ,  1972). Accumulating evidence showed that 
apoptosis mediated neuronal death during development of neurodegenerative diseases 
(Liu et al ,  2009, Rotli and Shacka, 2009, Tatton and Olanow, 1999). The classic 
hallmarks of apoptosis are cliromatin condensation, DNA fragmentation, cytoplasmic 
condensation, phosphatidylserine (PS) externalisation, cell shrinkage, membrane 
blebbing, cytoskeletal collapse, and the formation of apoptotic bodies that are eventually 
eliminated and are digested by macrophages or neighbouring cells (Figure 1.2). A wide 
range of regulatory factors and proteases are involved in the apoptosis and are 
dependent of the triggering pathway.
Caspases, otherwise known as cysteiny 1 -aspartate proteases, are considered the core 
components of the apoptotic machinery. Caspases exist within cells as a family of 
inactive pro-enzymes that can be activated tlirough death receptors or via the 
mitochondria. Caspases can be categorised into two main groups; inflammatory 
caspases and apoptotic caspases (Nadiri et al ,  2006, Riedl and Shi, 2004). The former 
are the caspases involved in the maturation of cytokines and induction of inflammation 
(caspases-1,-4, -5, -11, -12, and -14) while the latter group are the caspases directly 
involved in apoptosis (caspases-2, -3, -6, -7, -8, -9, and -10). Apoptotic caspases can be 
further sub-divided depending on the length of their pro-domains, way of activation, 
inhibition, and release of inhibition into initiator caspases (caspase-2, -8, -9, and -10) 
and executioner caspases (caspase-3, -6, and -7) (Riedl and Shi, 2004).
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The signalling pathways leading to apoptotic cell death are initiated either intrinsically, 
i.e., as a result of DNA damage and mitochondrial dysfunction or extrinsically via death 
receptor pathways. The mitochondria is a key player in the intrinsic apoptotic pathway 
thr ough release of mitochondrial proteins, such as cytochrome C that activates caspases 
in the presence of ATP, forming the apoptosome-complex with Apaf-1 and pro-caspase 
9 (Liu et al ,  1996) and Smac/Diablo (Du et al ,  2000).The release of these 
mitochondrial proteins is mediated by the action of pro-apoptotic Bel-2 family proteins 
such as Bax (Desagher and Martinou, 2000). The Bcl-2 family is intracellular protein 
regulate the activation of procaspases. Thus, this family play an important role in 
intrinsically apoptotic signal induction. Bcl-2 family can be sub-divided into two classes 
that either promote (Bax, Bid, and Bad) or prevent (Bcl-2, Bcl-xl) apoptosis through 
release or blocking of cytochrome C from mitochondria (Yang E., 1995, Love, 2003b). 
Bcl-2 that inhibit apoptosis have been suggested to maintain neuronal survivor where it 
can support the survivor of sympathetic in the absence of nerve growth factors and 
inhibit the death signal induced by trophic factors (Rao, 2000, Love, 2003b, Friedlander, 
2003b). Thus Bcl-x proteins appear to regulate apoptosis in the adult CNS (Rao, 2000). 
Bcl-x expression is necessary during early development where It is found that Bcl-x 
deficient causes death of mice at embryonic day 13 due to extensive apoptosis (Rao, 
2000).
Conversely, multiple lines of evidence indicate that following oxidative stress injury and 
DNA damage, p53 requires to initiate and regulate the intrinsic apoptotic signalling 
pathway thr ough p5 3-mediated transcriptional activation of pro-apoptotic proteins such
10
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as Bax up regulation in neuronal excitotoxic injury and after traumatic or ischemic cell 
death in vivo (Friedlander, 2003a, Mattson, 2000, Xiang et al ,  1998, Love, 2003a, 
Raghupathi, 2004). However, other roles of p53-regulated mitochondrial apoptosis 
pathway have been shown such as regulating PUMA (P53 upregulated modulator of 
apoptosis), Noxa, and Bid that play a key role in specific cases of neuronal apoptosis 
(Nakano and Vousden, 2001, Ward et al ,  2004, Yu et al,  2001).
On the other hand, the extrinsic pathway is mediated by death receptors that either 
signal directly or indirectly via release of cytokines to trigger apoptosis (Chaparro- 
Huerta et al ,  2008). In spite of the existence of different types of cell death receptor, 
such as tumour necrosis factor (TNF) receptor and CD95 (Fas/APO-1), they induce 
apoptosis by the same basic mechanisms involving formation of a death-inducing 
signalling complex (DISC) in the plasma membrane. This DISC recruits pro-caspases 
and an internal death domain (DD) via a death effector domain (DED) interaction 
(Friedlander, 2003a).
Cross-talk between the intrinsic and extrinsic pathways can also occur (Figure 1.2). The 
signal starts extrinsically by triggering the death receptor that leads to activation of the 
intrinsic pathway (Luo et al ,  1998). For example, activation of caspase-8 extrinsically 
through Fas or TNF triggers the intrinsic apoptotic pathway by cleaving cytosolic Bid 
that presents a pro-apoptotic member of the Bcl-2 family that usually exists in an 
inactive form in the cytosolic fraction of living cells. The COOH-terminal part of Bid 
translocates to the outer mitochondrial membrane and triggers the release of cytochrome 
C that initiates apoptosis by engaging the intrinsic pathway (Figure 1.2) (Li et al,  1998).
11
C h a p t e r  1 :  In t r o d u c t i o n
Daalhraoaplor
I
MHocitowilrii
o o 
0 o o o 0
1
□
Figurel.2 Caspase activation through extrinsic (death-receptor) and intrinsic (mitochondria!) 
pathways.
The extrinsic pathway is initiated upon binding o f a ligand to cell death receptor that activates caspase-8, 
whereas the intrinsic pathway is mediated by caspase-9 activation through cytochrome C release. 
Activation o f caspase-8 or -9 may directly cleave caspase 3 and lead to apoptosis. Cross-talk between the 
intrinsic and extrinsic pathways can also occur. The signal starts extrinsically by triggering o f the death 
receptor that leads to activation o f the intrinsic pathway. Activation o f caspase-8 through Fas, induces 
cleavage o f a pro-apoptotic protein Bid. Fragmented Bid translocates to the mitochondria and results in 
cytochrome C release and activation caspase-9.
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1.2.2 Autophagy
Autophagy is a catabolic process responsible for the degrading or recycling damaged 
cell constituents through the liposomal machineiy. Autophagy is a highly organised 
process that can be discriminated from other cell death types by the presence of double- 
membranous sacs called autophagosomes that contain cytoplasmic dysfunctional j
organelles such as mitochondiia or endoplasmic reticulum (Yorimitsu and Klionsky, |
2005). Other hallmarks of autophagy are mitochondidal swelling and enlargement of the 
ER and the Golgi apparatus, while nuclear condensation and membrane blebbing may 
occur at late stages of autophagic death but are less prevalent compared to apoptotic cell 
death (Yorimitsu and Klionsky, 2005). Autophagy occurs in response to either 
extiacellular or intracellular stresses such as deprivation of nutrients, hypoxia, or cell 
organelle damage.
Two types of autophagy have been recognised depending on the mechanisms of 
autophagosome formation and their delivery of materials (Reggiori and Klionsky, 2002,
Wang and Klionsky, 2003). The first type is microautophagy and involves uptake of 
cytosolic compounds by direct engulfment and invagination of the vacuolar/lysosomal 
membrane. The second type is macroautophagy and involves digestion of damaged 
cytoplasmic organelles and long-lived proteins inside the cell by sequestering them into 
a 300-900mn diameter double-membrane vesicle called an autophagosome (Reggiori 
and Klionsky, 2002, Wang and Klionsky, 2003). Autophagosomes are thought to be 
formed at the perivacuolar, pre-autophagosomal structure (PAS) via elongation of 
small membrane structures known as autophagosome precursors (Yorhnitsu and
13
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Klionsky, 2005). The formation of autopliagosomes is initiated and regulated mainly by 
class III phosphoinositide 3-kinase, Beclin-1 and ubiquitin-like protein Atg8 (LC3). 
Once an autophagosome is formed it fuses in the cytoplasm with a lysosome to form 
an autophagolysosome where its contents are degiaded and recycled.
1.2.3 Necrosis
Necrosis is a form of cell death that results in cells bursting and releasing their contents, 
potentially triggering an inflammatory response in neighbouring cells. Necrotic cell 
death, in contrast to apoptosis, is characterized by cell dilation, loss of membrane 
integiity and random digestion of DNA. Necrosis is also usually associated with loss of 
ATP synthesis, which is thought to be linked to mitochondiial swelling and 
mitochondrial dysfunction (Lemasters et al  ^ 1999, Zhuang et ah, 2008). Necrosis is 
commonly initiated by calpains which are like caspases, executioners of cell death. 
Calpains are calcium dependent cysteine proteases activated by excessive increases in 
intracellular Ca^  ^resulting from disturbance of intracellular ER Ca^  ^homeostasis or 
influx Ca^  ^via membrane channels (Wie et al ,  2001, Yamashima). In the past, necrosis 
was considered an uncontrolled process that happened accidently in an umegulated 
manner. However, evidence has shown that necrosis can also be initiated via death 
receptors such as TNF in a regulated process called necroptosis (Degterev et al,  2005). 
Necroptosis participates in pathogenic diseases including ischaemic injuiy and 
neurodegeneration (Degterev et al ,  2005).
Necroptosis can be initiated by the triggering of death receptors, including CD95, 
CD95L and TNF receptors (Figure 1.3) (Hitomi et al,  2008, Holler et al,  2000). These
_
C h a p t e r  1 :  In t r o d u c t i o n
receptors usually activate the apoptotis pathway, however, in necroptosis the cell death 
triggered by these receptors occurs in a caspase-independent manner (Rosenbaum et ah, 
2010). The serine/threonine kinase activity of receptor-interacting proteins (RIPl and 
RIP3) is the major player in necroptosis. It is evident that RIPl combines with RIP3 to 
form a necrosome complex that is essential for the activation of necroptosis machinery 
(Hsu et al ,  1996, Vandenabeele et al ,  2010b, Zhang et al ,  2009). Absence of either 
RIPl or RJP3 therefore abrogates necroptosis. For example, Nicrostatin-1 that blocks 
the kinase activity of RIPl is able to protect cells from necroptosis (Degterev et al ,  
2005) RIPl-deficient T cells were also unable to perform necroptosis via CD95L, 
TRAIL or TNF receptors (Holler et al ,  2000). In addition, RIP3 depletion was shown to 
prevent necroptosis in the cells (Upton et al ,  2010).
The stability of the necrosome complex depends on the existence of caspase inhibitors. 
It has also been found that chemical agents mimicking the second mitochondria-derived 
activator of caspase (SMAC), lead to stabilization of the necrosome complex (Feng et 
al,  2007, He et al ,  2009). Another role of RIPl in necroptosis is activation of 
poly(ADP-ribose) polymerase 1 (PARP-1), that usually shuts down in apoptosis due to 
caspase activation. For example, it has been demonstiated that RIPl - deficient mouse 
embryonic fibroblasts are resistant to PARP 1 -induced cell death (Xu et al,  2006). Over 
activation of PARPl leads to mitochondrial release of apoptosis-inducing factor (AIF), 
which in turn results in large-scale DNA degradation and eventually further stimulates 
PARPl expression and PARP2 that is also involved in necroptosis (Los et al ,  2002). 
Other factors such as cyclophilin D, lysosomal membrane permeabilization (LMP), ROS
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generated by mitochondria or NADPH oxidase 1, pro-apoptotic B cellsand lymphoma 2 
(BCL-2) family members have been shown to play roles in the execution of necroptosis 
(Galluzzi and Kroemer, 2008, Vandenabeele et al ,  2010b).
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Figurel.3 TNFRI signalling pathways in necroptosis
a I On TNF binding, TNF receptor 1 (TN FRI) undergoes a conformational change, allowing the assembly 
o f TNFR complex I, which includes TNF receptor-associated death domain (TRADD), receptor- 
interacting protein 1 (R IPl), cellular inhibitor o f apoptosis proteins (cIAPs), TNF receptor-associated 
factor 2 (TRAF2) and TRAF5. On cIAP-mediated Lys63-ubiquitylation, RIPl can serve as a scaffold for 
the recruitment o f transforming growth factor-p activated kinase 1 (TAKl), TA Kl-binding protein 2 
(TAB2) and TAB3, which initiate NF-kB activation pathway (Box 2). Riboflavin kinase (RFK) bridges 
the TNFRI death domain to p22phox, the common subunit o f multiple NADPH oxidases, including 
N O X l, which also contributes to TNFa-induced necroptosis by generating ROS. On deubiquitylation by 
cylindromatosis (CYLD; and perhaps also by A20, cezanne or ubiquitin-specific peptidase 21 (USP21 )), 
RIPl exerts lethal functions, which can be executed by two distinct types o f cell death, b | The 
internalization o f TNFRI leads to the assembly o f TNFR complex II, which often contains TRADD, FAS- 
associated protein with a death domain (FADD), caspase 8, RIPl and RIP3 (also known as RIPK3). 
Normally, caspase 8 triggers apoptosis by activating the classical caspase cascade and cleaves, and hence 
inactivates, RIPl and RIP3. c | If  caspase 8 is blocked by pharmacological or genetic interventions, RIPl 
and RIP3 become phosphorylated and engage the effector mechanisms o f  necroptosis. Taken from 
(Vandenabeele et al., 2010a)
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1.3 Role of mitochondria in cell death
Mitochondria are important integrators in cellular regulatory processes and thus provide 
critical functions for cell sui*vival including intracellular Ca^  ^buffering, ATP 
production, and cell death triggering, while their dysfiinction can be a key determinant 
of cell death. Mitochondi'ia also can be a target and/or a source for ROS which in both 
cases may lead to deferent types of cell death. A variety of diseases including 
neurodegenerative diseases are linked to mitochondrial dysfunction and may be caused 
by the leakage of mitochondrial cell death regulator or the high-energy electrons in the 
respiratory chain that form ROS and in turn activate the mitochondrial penneability 
transition pore.
1.3.1 Mitochondrial permeability transition pores
The mitochondrial permeability transition pore (MPTP) is a non-selective voltage- and 
Ca^ -^dependent high-conductance channel, permeable to solute molecules less than 
1500 Daltons in mass (Zamzami and Kroemer, 2001). The molecular structure of MPTP 
is still uncertain however, the prevailing model proposed from experiments using 
inhibitors and reconstitution studies indicate that MPTP spans the outer and inner 
mitochondiial membranes and is composed of proteins from both mitochondiial 
membranes in addition to matrix proteins (Crompton, 1999, Woodfield et al ,  1998). 
Adenine nucleotide translocator (ANT), located in the inner mitochondrial membrane, 
the outer membrane voltage-dependent anion channel (VDAC), and matrix cyclophilin 
D are all core components of MPTP (Zamzami and Kroemer, 2001, Crompton, 1999, 
Woodfield et al ,  1998). Other constituents believed to be part of the MPTP are
_
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hexokinase, creatine kinase, the peripheral benzodiazepine receptor and pro-apoptotic 
Bax/Bcl-2-like proteins (Shimizu et a l,  1999, Zamzami and Ki'oemer, 2001).
Based on the aforementioned proposed model, the MPTP complex contains multiple 
targets for stimulus that promote the opening of the mitochondi'ia pore, such as adenine 
nucleotide depletion (Marzo et a l, 1998), mitochondrial depolarization (Sharov et a l,  
2005), mitochondrial calcium overload (Lemasters et al, 2009), oxidative stress (He and 
Lemasters, 2002), or elevated phosphate concentrations (Javadov et a l, 2009). MPTP 
opening as occurs in ischaemia leads to cell death involving different metabolic 
consequences such as uncoupling of the respiratoi'y chain with collapse of mitochondi ial 
membrane potential A'Pm and cessation of ATP synthesis, increased cytoplasmic Ca^ ,^ 
elevation of ROS levels , and mitochondrial release of intermembrane sequestered 
proteins (Baines, 2009, Rajesh et a l,  2003).
1.3.2 ATP Production
Mitochondria are the primary generators of cellular energy through coupling of the 
electron transport chain. The type of cell death following extiinsically or intrinsically 
mediated cell death signalling is mainly dependent on cellular ATP levels (Eguchi et al, 
1997). Apoptotic cell death requires ATP to be accomplished while depletion of ATP 
blocks apoptosis and induces necrosis (Eguchi et a l ,  1997). On the other hand, cell 
death also can be switched from necrosis to apoptosis when cells are sufficiently 
supplemented with glycolytic substi'ates as an alternative source of ATP (Jae-Sung et 
al, 2003). ATP-dependent cell death is mediated by cytocluome C, which is an essential 
component of the electron transport chain. Cytochiome C resides within the
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mitochondrial intennembrane space and acts as an electron canier, caiTying one electron 
from b-cl complex (complexIII) to cytochiome oxidase complex (complex IV). Release 
of cytochrome C into the cytoplasm as a result of and extrinsic or intrinsic apoptotic 
signal leads to the formation of apoptosome complexes, with apoptosis protease 
activating factor-1 (APAF-1) and procaspase-9 in an ATP-dependent manner 
(Friedlander, 2003a). These complexes result in the activation of caspase-9 that is 
responsible for caspase-3 recruiting in generating apoptosis cascade events (Riedl and 
Shi, 2004).
1.3.3 Oxidative stress and neurodegenerative disease:
1.3.3.1 Reactive Oxygen Species (ROS) and the biology o f oxidative stress:
Principally, ROS consist of oxygen free radicals and other associated compounds 
including superoxide free radicals, hydiogen peroxide, singlet oxygen, nitric oxide 
(NO), and peroxynitrite. The production of ROS is associated with amyotrophic lateral 
sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD) and other 
neurodegenerative diseases (Bains and Shaw, 1997, Migliore and Coppedè, 2009, 
Migliore et a l, 2005). Although several of free radicals are produced at low levels 
during normal physiological conditions, they are normally scavenged by endogenous 
antioxidants, which play a pivotal role in preventing oxidative stress (Bains and Shaw, 
1997). The hydroxyl radical is the most reactive oxygen free radical generated from 
hydi'ogen peroxide in the presence of feiTous iron, which is at high concentrations in 
brain tissue making neurons particularly susceptible to ROS insult (Fubini and Hubbard, 
2003).
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In addition, the brain has several unique anatomical and physiological features that 
make it susceptible to free radical insults. The brain consumes approximately twenty 
percent of the total amount of oxygen in the body and has the highest oxygen metabolic 
rate compared to any other organ in the body (Turton and Hooson, 1997). Additionally, 
the brain has an inadequate defence system against oxidative stress where catalase 
activity in the brain is significantly lower than in other body organs. For instance, the 
brain contains only 10% of the catalase activity that is present in the liver (Turton and 
Hooson, 1997). Brain tissues also contain increased amounts of unsaturated fatty acids 
that can be metabolised by oxygen free radicals (Turton and Hooson, 1997). These 
factors together all lead to an increased probability of ROS production.
Mitochondria have vital multiple functions in the cell including amino acid biosynthesis, 
fatty acid oxidation, steroid metabolism and maintenance of the cellular energy reseiwes 
via ATP production fiii'ough the electron tiansport chain. Nevertheless, mitochondria are 
known to be a significant source of superoxide radicals and other ROS that are 
associated with oxidative stress (Malinska et a l ,  Mathisen et a l,  2007). ROS produced 
by mitochondria could be derived from electrons leaking from the transport chain to 
oxygen at sites of high oxygen potential. Under normal conditions it is thought that 1 % 
of mitochondrial electron flow contributes to the formation of superoxide radicals (O2 ) 
(Klein and Ackerman, 2003). Also, defects in electron transport complexes or other 
peiturbations of mitochondrial machinery can be responsible for excess production of 
ROS, leading to oxidative stress (Atlante et a l,  2001). Normally, when ROS production 
is at low levels, ROS are dealt with by enzymes such as mitochondiial superoxide
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dismutase (SOD) that convert oxide radicals into H2O2 and O2 . Peroxide is then 
converted via glutathione peroxidase or catalase to non-harmful substances that can be 
safely excreted (Edwards et a l ,  1998, Fiers et a l,  1999). However, this system does not 
work in cases of excessive ROS generation resulting in oxidation of cell components 
such as DNA, mitochondria, cell membrane lipids and protein making them 
dysfunctional. ROS can also lead to ineversible damage tliroughout the cell by 
activating cell death pathways through the release of cell death regulators from the 
mitochondria.
1.4 Cell cycle and neurodegenerative diseases
1.4.1 Regulation of the cell cycle
The cell cycle of eukaryotic cells include four essential phases: Gap or Growthl (Gl) 
phase, DNA synthesis (S) phase. Gap or Growth2 (G2) phase and mitosis (M) phase 
(Figurel.4). Cell cycle progression through these orderly phases is highly controlled by 
a group of proteins including cyclins, cyclin-dependent kinases (CDKs), cyclin- 
dependent kinase inhibitors (CKIs), DNA replication proteins and checkpoint proteins 
whose activity is central to this process (Henmp and Yang, 2007). A diagrammatic 
representation of cell cycle regulators is presented in figure 1.4. CDKs are 
serine/tlireonine kinases that play an important role in regulating cell cycle progression 
through binding to cyclins and forming cyclin-CDK complexes. The majority of cells 
when inactive remain in GO phase (a specialized form of Gl) such as post-mitotic 
neurons. However, the cells that enter the cell cycle progress thiough each phase by the
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action of cyclin binding to the appropriate CDK partner in order to activate kinase 
activity (Herrup and Yang, 2007).
Cyclins A, B, D, and E are four essential cyclins that have been described as principal 
components of the cell cycle that are up-regulated or down-regulated depending on the 
phase of the cell cycle. During Gl phase, cyclins D and E are considered core 
components t controlling the phase (Currais et a l ,  2009). Mitogenic signals such as 
extracellular growth factors trigger D-type cyclin (Dl, D2, and D3) induction, which is 
an important step to initiate the cell cycle. D-type cyclins join together with CDK4 and 
CDK6 to form active kinase complexes. The main functions of cyclin D/CDK4,6 
complexes include phosphorylation of the retinoblastoma protein (Rbp) and regulating 
tianscription of genes associated with DNA replication. D/CDK4,6 complexes are also 
important for preventing the inhibitory influence of the Cip/Kip family of CKIs 
including p21 and p27 on CDK2 that forms an active kinase complex with cyclin E in 
the late Gl phase that is necessary for re-phosphoiylation of Rbp and ensures the Gl/S 
tiansition (Herrup and Yang, 2007, Cunais et a l ,  2009).
Once cells are in S phase, the cyclin A/CDK2 complex controls progression by 
phosphorylating various proteins specific to S phase and this result in DNA replication. 
Following completion of S phase, cells enter the G2 phase of the cycle, which is 
regulated by cyclin A/CDKl and cyclin B-CDKl that appears in late G2. Cells enter the 
M phase with the upregulation of CDKl that associated with cyclin A, which ensures 
completion of M Phase before the cells divide into two separate daughter cells (Herrup 
and Yang, 2007, CuiTais et a l,  2009). Kinetics of the cell cycle are also regulated
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thi'ough two families of CDKIs that prevent the formation of cyclin/CDK complexes by 
forming inactive complexes or by acting as competitive CDK ligands. The two 
subclasses of CDKIs that are the inhibitors of cyclin D-dependent kinases are INK4, 
which is specific for the Gl phase CDKs (CDK4 and CDK6), Cip/BCip, which are 
inhibitors of cyclin D-, cyclin E-, and cyclin A-dependent kinases. ES1K4 contains four 
members plb^ *^^ '^  ^ pjgiNic4b^  pjgiNK4c pj^ i^Nic4d Cip/Kip includes p21^'^\
pi?®"' and (Hemip and Yang, 2007, Cunais et a l,  2009).
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Figurel.4 Cell cycle regulation
The cell cycle is conposed o f four distinct phases: the first gap phase (G l); the DNA synthesis phase (S); 
the second gap phase (G2); and finally mitosis (M). Movement through the cell cycle is driven by the 
activities o f  conplexes o f  cyclins and cyclin-dependent kinases (CDKs), which phosphorylate 
retinoblastoma (RB)-family, thereby blocking their growth-inhibitory functions and permitting cell-cycle 
progression. The RB functions at the activity o f  factors belonging to the E2F family o f transcriptional 
regulators. E2Fs promote proliferation by inducing expression o f genes required for cell cycle 
progression, DNA replication and mitosis. By inactivating E2Fs, the RB tumor suppressor inhibits 
expression o f these genes resulting in a block to cellular proliferation. This role o f  RB is particularly 
inportant in stress responses to DNA damage and oxidative stress. Advancement through Gl phase is 
facilitated by the D-type cyclins (D l, D2, D3,), which form active conplexes with CDK4 or CDK6, and 
E-type cyclins (E l, E2,) in combination with CDK2. Cyclin-D-CDK4 and cyclin-D-CDK6 complexes 
are active when associated with p21 or p27 CDK inhibitors (CDKIs) taken from (Coleman et a i ,  2004).
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1.4.2 Neurons and the cell cycle
Neurogenesis originates prenatally by cell division at two gemiinal compartments: The 
ventricular zone (VZ) and the sub-ventiicular zone (SVZ). Once neurons leave the VZ 
or SVZ, they become permanently post-mitotic, meaning that their cell cycles are kept 
in check (Herrup and Yang, 2007). However, mountains of evidence have shown that 
adult neurons have the ability to re-enter the cell cycle with the expression of cell cycle 
proteins and initiation of DNA replication as common mechanisms during 
neurodegenerative disorders diseases leading to neuronal loss (Chaparro-Huerta et ah, 
2008, Greene et a/., 2007, Majd et al., 2008, Pelegri et a l,  2008). For instance, studies 
have reported that in AD, neurons undergo apoptosis post cell cycle re-entry. Gl 
progression of AD neurons is consistent with the expression of late Gl markers such as 
cyclin E and CDK2 (Nagy et a l,  1997). Yang et a l  (2001) have found that in AD 
brains, neurons duplicate their genome prior to their death. These findings suggest that 
AD neurons may complete Gl and S phase and enter G2 phase before dying.
1.4.3 Cell cycle regulator functions in post mitotic neurons
After leaving the VZ and SVZ zones, neurons become terminally differentiated and 
irreversibly withdraw fiom cycling. However, expression of cell cycle regulators is not 
completely inactivated. The absence of detectable cell division in the post mitotic 
neuron suggests that cell cycle regulators exert cell-cycle-independent functions in post 
mitotic neurons (Frank and Tsai, 2009). Indeed, studies have reported that cell cycle 
proteins have important roles in post mitotic neurons including neuronal migration, 
axonal elongation, axon pruning, and synaptic maturation and plasticity (Franlc and Tsai,
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2009, Goukassian et a l ,  2001, Wu et a l,  2001). For example, Cip/Kip proteins that 
inhibit a broad spectrum of CDK-cyclin complexes during the cell cycle, act as 
regulators of cell motility and migration in the post mitotic neuron (Franlc and Tsai, 
2009), This regulation by Cip/Kip is mediated by inhibiting the Rho signalling pathway 
in different ways depending on the Cip/Kip family member involved, e.g. p27^ ^^  ^
competes for binding to Rho A with guanine nucleotide exchange factors (GEFs), 
whereas p57^^  ^ sequesters LIM-domain-containing protein kinases (LIMKs) in the 
nucleus and ultimately inliibits the Rho signalling pathway (Frank and Tsai, 2009). Cell 
cycle-independent functions of cell cycle regulators are likely to expand with the 
continued study of cell cycle control and may allude to further physiological neuronal 
functions.
1.4.4 Cell cycle abnormalities in neurodegenerative diseases 
A substantial body of evidence links the failure of cell cycle regulation in post mitotic 
neurons to neuronal cell death pathways that lead to several neurodegenerative disorders 
(Greene et a l ,  2007, Majd et al, 2008). Experimentally, initiation of the cell cycle in 
mature neurons leads to cell death instead of cell division, whereas blocking the cell 
cycle leads to rescue of the cells (Liu et a l, 2010). Early experiments showed that 
inti'oduction of large transformation (T) antigen from the SV40 vims to post mitotic 
neuron cells led to cell death. Large T antigen inactivates Rb protein leading to the 
release the transcription factor, E2F1 that subsequently leads to up-regulation of many 
cell cycle genes (al-LFbaidi et a l, 1992, Feddersen et al, 1997). Therefore, when large T
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antigen was iiiti'oduced to the neurons the cell cycle was released. These cells were 
shown to complete Gl and S phases but died shortly prior M phase initiation.
The link between cell cycle initiation and neuronal death is also found in response to 
withdrawal of nerve growth factor (NGF) that causes an unexpected increase in the 
levels of cyclin D mRNA (Henup and Yang, 2007, Persengiev et al, 1999). 
Furthermore, cell cycle block initiated tlrrough NGF with CDK inliibition suppressed 
neuron death giving another strong indication that the neuron cell cycle must be 
regulated to avoid death (Liu et a l ,  2004). In addition, re-expression and activation of 
the cell cycle has been observed in AD neurons that undergo apoptosis post cell cycle 
re-entry (Currais et al, 2009). Cyclins, CDKs and other cell cycle regulators are 
expressed in the AD brain. Gl progression of AD neurons is consistent with the 
expression of late Gl markers, cyclin E and CDK2 (Nagy, 1997). Yang et a l  (2001) 
have found that AD neurons duplicate their genome prior to their death. Interestingly, 
CDKIs such as pjgiNK4c pjpiNK4d also been detected in
pyi*amidal neurons of the hippocampus of AD patients (Arendt et a l,  1998). Elevation 
of CDKIs is an attempt by the terminally differentiated injured neurons to abort re-entiy 
into the cell cycle (Lars Rôdel et al., 1996). This supports the hypothesis that neuronal 
death in AD is a response of cell cycle re-entry which is a critical event in the pathology 
of AD.
Similarly, various damaging stimuli such as excitotoxicity and toxic concentrations of 
amyloid-p can drive cell cycle re-expression and cell death in cultured CNS neurons 
(Lee et al, 2010). Studies also showed increased Cyclin D and E levels following
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freatment of cerebellar gi*anule neurons with kainic acid (Giardina et al, 1998, 
Ester;Verdaguer et al, 2002). The previous finding has been confirmed in an in vivo 
excitotoxicity model, where cyclin D and CDK4 were up-regulated in apoptotic brain 
areas following kainic acid treatment (Ino and Cliiba, 2001). In conclusion, failure to 
conti'ol the neuronal cell cycle leads to cell cycle initiation and is laiown to be a root 
cause of several neurodegenerative diseases. Therefore, neuronal cell cycle control is an 
important factor to be considered in the study of neurodegenerative diseases.
1.5 HT-22 mouse hippocampal immortalised cell line
The HT-22 mouse hippocampal cell line is derived firom HT-4 immortalised mouse 
hippocampal cell line. HT-4 cells are immortalised from primary mouse hippocampal 
neurons using a temperature-sensitive small vims-40 T antigen (Frederiksen et al,  1988, 
Lendahl and McKay, 1990, Morimoto and Koshland, 1990). The HT-22 characterized 
by lack of ionotropic glutamate receptors where NMD A, aspartate, AMP A and kainate 
have not been found toxic at concentrations up to 10 mM (Maher and Davis, 1996). In 
addition, the glutamate receptor antagonists APV and MK-801 do not block glutamate 
toxicity in the HT-22 cells (Maher and Davis, 1996). However, HT -22 cells are sensitive 
to glutamate and the major cause of glutamate-induced toxicity in HT-22 is that high 
levels of extracellular glutamate limit or even reverse of the cystine/glutamate 
exchanger and results in lowering cystine uptake into cells which ultimately leads to 
GSH depletion and ROS accumulation (Maher and Davis, 1996, Tan e ta l ,  1998a).
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L6 Aims o f the study
The complexity of glutamate-induced neuronal cell death has so far precluded any final 
conclusion to the exact mechanism that may lead to the neuronal cell death. 
Consequently, causal therapies of glutamate-induced cell death have failed to protect 
patients against neuron injury (Greene and Greenamyre, 1995, G wag et al, 1995). 
Therefore, include the whole picture of glutamate-induced neuronal cell death when 
considering treatment avenues necessitating for a better understanding of glutamate- 
induced cell death mechanisms. This study aims to investigate glutamate-induced 
neurotoxicity mechanism via a receptor independent pathway lies in the contribution of 
oxidative stress mechanisms. This study investigated the biochemical pathways 
associated with glutamate-induced cell death using HT-22 immortalised cell lines as a 
valuable tool in understanding molecular and cellular processes relevant to glutamate- 
induced hippocampal injury.
The first aim of this thesis was therefore to investigate the contiibution of glutamate- 
induced oxidative stress to cell death pathways in HT-22 mouse hippocampal cell line. 
By analysing morphological and biochemical parameters related to cell death types, a 
comprehensive approach was undertaken to identify the glutamate-induced HT-22 cell 
death characterisation including:
1. Study the moiphological changes in glutamate-induced HT-22 cell death 
including cells volume and Phosphatidylserine externalisation.
2. Study the involvement of caspases and P53 in glutamate-induced HT-22 cell 
death.
_
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3. Study the involvement of autophagy in HT-22 glutamate-induced cell death.
After the establishment of the mechanism involved in glutamate-induced cell death, the 
possibly aberrant mitochondrial function behind glutamate-induced HT-22 cell death 
was studied to:
1. Evaluate the effect of glutamate-induced HT-22 cell death on the mitochondrial 
membrane potential AYm and the mitochondiial permeability transition pores as 
an important parameters of mitochondrial function used as an indicator of cell 
health.
2. Evaluate mitochondria coixelation with production of reactive oxygen species in 
response to glutamate injury.
On the other hand, one of the mechanisms linked to oxidative neurodegeneration is 
abenant re-entry into the cell cycle (Greene et al, 2007, Majd et a l,  2008). In this 
study, experiments were designed to test the hypothesis that there is a casual link 
between L-glutamate-induced cell death in HT-22 cells and the cell cycle including:
1. Examine the effect of glutamate on HT -22 cell cycle at different time points of 
glutamate treatment.
2. Examine the ability of glutamate to induce cell cycle activation in HT -22 cells 
where its cycles were synchronised using either serum starvation methods or 
chemicals to aiTest the cell cycle in a given phase. Once the cells were 
synchi'onised, the effect of glutamate was investigated firstly in cells arrested in
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different stages of the cell cycle and secondly, following release of the cells into 
the cell cycle.
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2 Materials & Methods
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2.1 Materials
L- Glutamate, L-glutamine (lOOx), penicillin/ streptomycin (antibiotics solution at 50 
U/ml), Trypsin-EDTA solution (Ix), Dulbecco’s phosphate buffered saline (DPBS) (Ix) 
- free, (DPBS) (Ix) + (0.9mM Calcium Chloride, 0.5mM
Magnesium Chloride) free, Triton X-100, dimethylsulfoxide (DMSO), propidium 
iodide, RNase A, N-acetyl-l-cysteine (NAG), cycloheximide, tetiamethylrhodamine 
ethylester (TMRE), Carbonyl cyanide 3-chlorophenylhydrasone (CCCP), Cyclosporine 
A, Annexin V-FITC Apoptosis Detection Kit, Necrostatin-1, Nocodasol, 
Bromodeoxyuridine (BrdU), Diphenylene iodonium (DPI) and nordihydioguaiaretic 
acid (NDGA) were purchased from Sigma-Aldiich Ltd, (Poole, UK). 
Bensyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD-FMK was bought from 
Bachem (Bubendorf, Switserland). JunN-terminal Kinase inhibitor was purchased from 
Calbiochem (Nottingham, UK).
5-(and -6)-Chloromethyl-2',7'-dichlorodihydrofluorescein diacetate acetyl ester (CM- 
H2DCFDA), MitoSOX (C43H43N3IP), 3,6-Acridinediamine, N,N,N',N'-tetramethyl-, 
monohydi'ochloride (Acidine orange), l,2-Bis(2-aminophenoxy)ethane-N,N,N',N'- 
tetraacetic acid tetrakis(acetoxymethyl ester) (B APT A-AM), 7 - Amino-actinomycin D 
(7-AAD), 2,5 -Pyrrolidinedione, l-[[[3',6'-bis(acetyloxy)-3-oxospiro[isobensofuran-
l(3H),9'-[9H]xanthen]-5(or6)-yl] carbonyl]oxy] (CFSE), cell culture media; Dulbecco’s 
modified Eagle’s medium (DMEM without L-glutamine), foetal bovine serum (FBS), 
Western Breese Chemiluminescence western blot kit (blocker/diluent (Part A), 
blocker/diluent (Part B), antibody wash solution, secondaiy antibody solution,
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Chemiluminescent Substrate), NuPAGE No vex 4-12% Bis-Tris Gel, PVDF membranes 
were obtained from Invitrogen (Paisley, UK). Lactate dehydrogenase (LDH) detection 
kit and bovine serum albumin were obtained from Roche (Lewes, UK). Bio-Rad Protein 
assay kit obtained from Bio-Rad, Hercules CA. Staurosporine was purchased from 
Alexis Biochemicals, Bingham UK. Monoclonal anti-p53 antibody was purchased from 
Cell Signaling Technology, UK. Primer of caspase-9,P53 and GAPDH obtained from 
Integrated DNA technologies, USA. All cell culture flasks, Universals and Falcons tubes 
were obtained from NUNC.
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2.2 Methods
2.2.1 Cell Biology
2.2.1.1 Cell culture
Immortalised mouse hippocampal cell line HT-22 were a gift from Dr. Pamela Maher, 
La Jolla Research institute, California. HT-22 cells were cultured in Dulbecco's 
modified Eagle's medium (DMEM) containing 10% foetal bovine serum (FBS), 50 U/ml 
penicillin/streptomycin and 2mM L-glutamine. They were grown in 75 cm  ^ flasks at 
37°C in air/ 5% CO2 . Cells were passaged every four days using complete culturing 
medium. First, the cells were washed with Ca^ '^ '^ Mg^ '^ -free PBS followed by treatment 
with 2ml Trypsin/EDTA for detacliment after which the cells were plated at 1:10 
dilution.
2.2.1.2 Cells treatment
Unless indicated otherwise, HT-22 cells were seeded at 3 x 10^  in 25cm^  falcon flasks 
and giown for 24 h. once 50% confluence was achieved and prior to experimental 
treatment, the medium was replaced by fresh media containing 10% FBS. Where 
indicated, the cells were pre-treated with the experimental compounds at the desired 
concentration for 30 minutes prior to L-glutamate addition.
2.2.1.3 Lactate dehydrogenase release assay
For the measurement of cell viability, aliquots of the media were removed at the 
indicated time points and assayed for lactate dehydrogenase (LDH) release. HT -22 cells 
were seeded at 8 x 10^  cells in 24-well plates and gi'own for 24 Hours. Once 50% 
confluence was achieved and prior to treatment, the medium was replaced with new
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complete culturing medium containing 10% FBS. Cells were then treated with 3, 5, or 
10 mM L-Glutamate from a 200 mM stock L-glutamate solution in milliQ water. 
Following the cytotoxic ti eatment, llOpl aliquots of post treatment medium were taken 
at the indicated time points and assayed for LDH according to the manufacturer's 
instmctions (Roche, Lewes, UK). Briefly, supernatant were spun at lOOOg for 5 minutes 
to remove any existed debris then lOOpl aliquots removed to 96-well plate. Samples 
were incubated for 30 minutes with lOOpl of LDH reaction mixture prepared according 
to the manufacturer's instmctions (Roche, Lewes, UK), Absorbance was measured at a 
wavelength of 490 nm using ELISA reader. Cell death is recorded as a percentage of 
total lysis as calculated from tieatment with 0.1% Triton X-100 to release the total LDH 
from each well at the end of each experiment. Background was assayed using lOOpl of 
complete medium.
2.2.2 Flow cytometry experiments
2.2.2,1 Measurement o f  cellular reactive oxygen species
DCFDA is a non-fluorescent dye (until oxidised by ROS in the cell) used to detect ROS 
production. Once DCFDA is inside the cell cytosol, it is cleaved by non-specific 
intracellular esterases and can no longer pass out of the cell membrane. The reduced de- 
esterified product becomes the fluorescent compound 2% 7’-dichlorofluorescein upon 
oxidation by ROS. Measuring DCFDA fluorescence reflects the amount of ROS present 
in the cells (Bass et ah 1983;Miyamoto et a l  1989).
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Figure2.1 Principle o f DCFDA mechanism.
Once DCFDA permeates in the cell, it is trapped 
in the cell via cleave it by non-specific 
endogenous esterase. DCFDA become florescent 
when it oxidise by ROS in the cells allowing to 
measure the amount o f ROS in the cell using flow 
cytometry (Bass et al., 1983).
Cells from 25 cm  ^flasks were frypsinised and centrifuged for 3 minutes at 130 x g using 
a benchtop centrifuge. The cells were re-suspended in PBS (containing Ca^^ and Mg^ "^ ), 
spun down again and re-suspended in a falcon tubes in 1 ml PBS. The cells were loaded 
with 5 jliM  of fresh stock solution of DCFDA ( prepared in DMSO) and incubated for 30 
minutes at 37°C and 5% CO2 . The stock solution and cell undergoing loading were kept 
under low light conditions due to the high susceptibility of DCFDA to photooxidation. 
After washing and resuspension in PBS, the cells were kept on ice until measured 
DCFDA florescence was measured using Beckman Coulter Epics XL flow cytometer. A 
minimum of 10,000 events were acquired in list mode, while gating the forward and side 
scatters to exclude cell debris, and analysed in FL-1 (520 nm emission).
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2.2.2.2 Measurement o f mitochondrial reactive oxygen species
MitoSOX, [3, 8-phenanthridinediamme, 5-(6'-ü*iphenylphosphoniumliexyl)-5,6 dihydro-
6-phenyl], is a flu erogenic indicator developed to detect mitochondrial superoxide in the 
living cells. MitoSOX is permeant dye through the live cell membrane. Once MitoSOX 
is in the living cells it rapidly and selectively targets the mitochondria and is oxidised by 
superoxide, if there is any, and exhibits red fluorescence that can be analysed using a 
flow cytometer or by confocal microscopy. However, MitoSOX dye do not oxidised by 
other ROS or reactive nitiogen species (RNS) that distinguishes mitochondrial 
superoxide from the other ROS present in the system (Robinson et a l, 2008). Cells from 
25 cm^  flasks were trypsinised and centrifuged for 3 minutes at 130 x g using a benchtop 
centrifuge. The cells were re-suspended in PBS (containing Ca^ a^nd Mg^^, washed 
once and finally re-suspended in a falcon tubes in 1 ml Hanlc’s Buffered Salt Solution 
(HBSS) containing calcium and magnesium. The cells were loaded with 5 pM of fi*esh 
stock solution of 5mM MitoSox in DMSO and incubated for 10 minutes at 37°C with 
5% CO2 . After washing and re-suspension 3 times in HBSS, the cells were kept on ice 
until MitoSox fluorescence was measured using a Beckman Coulter Epics XL flow 
cytometer. A minimum of 10,000 events were acquired in list mode, while gating the 
forward and side scatters to exclude cell debris, and analysed in FL-3 (620 nm 
emission).
2.2.2.3 Autophagic vacuole detection by Acridine Orange staining
To examine autophagic cell death in HT-22 cells Acridine orange staining was 
performed. Acridine orange is a cell-permeable selective fluorescent dye for nucleic
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acid. However, Acridine orange also enter acidic compartments associated with 
autophagic vacuoles such as lysosomes and become protonated and sequestered. In 
low PH conditions, the dye emits orange light that can be detected by flow cytometer or 
confocal microscopy. Following HT-22 cells tieatment in 25 cm ,^ growth medium was 
replaced with 5ml warm DMEM FBS-free medium. Acridine Orange was added at 2 pg 
final concentration from 2mg/ml AO stock and then the cells incubated with acridine 
orange for 20 minutes. The medium was then removed and cells washed 3 times with 
PBS. Flasks were then tiypsinised and centiifuged for 3 minutes at 130g using a 
benchtop centrifuge. The cells were re-suspended in PBS and kept on ice until measured 
the fluorescence using Beckman Coulter Epics XL flow cytometer. A minimum of
10,000 events were acquired in list mode, while gating the forward and side scatters to 
exclude cell debris, and analysed using FL-1 for green fluorescence (520 nm emission) 
and FL-3 for red fluorescence (620 nm emission)
2,2.2,4 Mitochondrial membrane potential
Changes in mitochondrial membrane potential were examined via flow cytometery 
using tetramethylrhodamine ethylester (TMRE) as a fluorescent probes to monitor and 
quantitate ATm. TMRE is a lipophilic dye that accumulates in the mitochondria 
depending on AWm. The cells were re-suspended in 1 ml PBS containing 5 mM 
glucose. Cells were loaded with 100 nM TMRE for 40 minutes (37 °C) prior to analysis 
with a Beckman-Coulter Epics XL. A positive control was prepared by adding 20pM of 
the uncoupler carbonyl cyanide 3 -chlorophenylhydrasone (CCCP) that causes 
mitochondrial depolarisation. The positive control cells were incubated with CCCP
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at room temperature for 3 minutes prior loading with TMRE. After washing and re­
suspension in PBS, the cells were kept on ice until TMRE fluorescence was measured 
by flow cytometry. A minimum of 10,000 events were acquired in list mode, while 
gating the forward and side scatters to exclude cell debris, and analysed in FL-3 (620 nm 
emission).
2.2.2.S Annexin V-FITC
Externalisation of the negatively charged phospholipid phosphatidylserine (PS) is 
considered a classic sign of apoptosis. In normal, viable cells, PS is not present in the 
outer layer of plasma membrane bilayer. PS relocated fi*om the inner to the outer 
membrane layer is an early event of apoptosis. Based on this fact, the apoptosis can be 
detected using Amiexin V-FITC that has a high affinity to PS in the presence of calcium 
(Ca^ )^. To discriminate apoptotic ftom dead cells, propidium iodide (PI) can be used to 
identify the dead cells (Figure 2.1). In early apoptosis the cells stain positive with 
Annexin V-FITC but are unstained for PL As these cells began to die, they become 
double positive. In some form of necrosis, the cells are only PI stained. In healthy cells 
with intact cell membrane, cells cannot be stained with either PI or Annexin V-FITC.
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Figure2.2 Schematic representation of Annexin V-FITC as a probe to detect cells that 
have expressed phosphatidylserine on the cell surface.
At early apoptosis process disrupting phospholipid asymmetry occurs and leads to the 
exposure o f phophatidylserine on the outer leaflet o f the cytoplasmic membrane. The 
combination o f Annexin V-FITC and propidium iodide discriminate early apoptotic cells 
(Annexin V-FITC positive), late apoptotic and/or necrotic cells (Annexin V-FITC and 
propidium iodide positive), and normal cells (unstained) by using flow cytometry.
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HT-22 cells fi'om 25 cm^  flasks were tiypsinised and centrifuged for 3 minutes at 130 x 
g using a benchtop centrifuge. The cells were re-suspended and washed with PBS. The 
cells were then re-suspended in annexin-binding buffer at a density of 10^  cells per ml. 
Annexin V conjugate was added at 5 pL to each 100 pL of cell suspension and cells was 
incubated in the dark at room temperature. After 15 minutes incubation, 400 pL of 
Amiexin V Binding Buffer and 1 pg per ml of PI was added to the cells and mixed 
gently. The cells were kept on ice until measured by Beckman Coulter Epics XL flow 
cytometer. A minimum of 10,000 events were acquired in list mode, while gating the 
forward and side scatters to exclude cell debris, and analysed in FL-1 for Annexin V 
(520 nm emission) and FL-3 for PI (620 nm emission)
2,2.2.6 Cell cycle assays
2.2.2.6.1 Propidium iodide (PI) staining
Flow cytometry was used to quantitative the nuclear DNA content of HT-22 cells. PI 
was used to bind to the DNA in suspension of permeabilised cells where the amount of 
PI fluorescence is proportional to the amount of DNA in the cells. Since PI also binds to 
RNA the cells were treated with RNAase prior to adding PI. In order to achieve an 
accurate DNA profile it was important to exclude cells debris and cells aggregates in 
flow cytometer to avoid false interpretations.
Treated HT-22 cells flom 25 cm  ^ flasks were trypsinised and centrifuged for 3 minutes 
at 130 X g using a benchtop centrifuge. The cells were washed with PBS. The pellet was 
then re-suspended with 200 pi ice-cold PBS. While vortexing, dropwise ice-cold fixing 
buffer (70% ethanol in %PBS) to 2 ml was added to fix the cells. Continuous vortexing
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is critical to achieve (i) full fixation and (ii) complete dissociation of clumped cells. The 
cells were stored overnight at +4°C. After spimiing to remove ethanol, cells were 
washed with the PBS. lOpM of RNAse was added and then lOpl of 1 mg/ml PI stock 
added to each sample and incubated in the dark at 37°C for 30 minutes. After incubation 
cells stored on ice and analysed using a Beckman Coulter Epics XL flow cytometer. A 
minimum of 10,000 events were acquired in list mode, while gating the forward and side 
scatters to exclude cell debris and further gating in the auxiliary scatter and FL3 to yield 
a good signal of discrimination between singlets or doublets. Cells were then analysed in 
FL-3 (620 nm emission)
2.2.2.6.2 Bromodeoxyuridine (BrdU) incorporation
Bromodeoxyuridine (BrdU) immunofluorescent staining was used to quantitate DNA 
synthesis in the HT-22 cells. BrdU incorporate into newly synthesised DNA when the 
cell is in the DNA synthesise phase of cell cycle (S Phase). Specific anti-BrdU 
fluorescent antibodies were used to measure the levels of cell-associated with BrdU by 
flow cytometry.
After the treatments of HT-22 cells with the experimental substances and prior to the
cells being haiwested and fixed, BrdU was incorporated into the cell population by
adding BrdU directly to the culture medium at final concentration of 10 pM. The cells
were incubated with BrdU for 30 minutes in the CO2 incubator at 37°C. Cells were
washed twice in PBS containing 1% FBS and then trypsinised and centiifuged for 3
minutes at 130 x g using a benchtop centrifuge. The pellet was re-suspended in 200 pL
of ice-cold PBS and was fixed by adding cold (-20°C) fixing puffer (70% ethanol in
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%PBS) by di'opwise while maintaining a vortex. The cells were stored overnight at 4°C, 
then cells pelleted at 500 x g for 10 minutes at 10°C and the supernatant was discarded 
carefully. To denature the DNA to produce single-stianded molecules, 1 mL of 2N 
HCl/Triton X-100 was slowly added to die cells while maintaining a vortex and the cells 
were incubated at room temperature for an additional 30 minutes. After spinning the 
cells at 500 X g for 10 minutes and discarding the supernatant, cells were re-suspended 
in O.IM Tris pH8 to neutialise the acid, centrifuged at 500 x g for 10 minutes and 10 pL 
of Anti-BrdU FITC per 10^  cells were directly added to the pellet. The cells were 
incubated for one hour at room temperature, washed once in 1 mL Tween/BSA/PBS and 
then lOpl of Img/ml PI stock added to each sample. The cells were analysed using a 
Beckman Coulter Epics XL flow cytometer. A minimum of 10,000 events were acquired 
in list mode, while gating the forward and side scatters to exclude cell debris. Cells were 
then analysed in FL-3 (620 nm emission) and FLl (520 nm emission).
2.2.3 Confocal microscopy imaging
For confocal microscopy, HT-22 cells were seeded at 1 x 10^  in 6-well plate containing 
cover slips and giown for 24 h. Once 50% confluence was achieved and prior to 
experimental treatment, the medium was replaced by fresh media containing 10% FBS. 
Where indicated, the cells were pre-treated with the experimental compounds at the 
desired concentration for 30 minutes prior to L-Glutamate addition. Formaldehyde-fîxed 
cells were then viewed using confocal microscopy with 20x objective. For live-cell 
imaging, cells were cultured on chamber slides at 16x 10^  followed by pre-treatment 
with the experimental compounds at the desired concentration for 30 minutes prior to L-
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Glutamate addition. All fluorescence images were captured with a Zeiss LSM 510 
fluorescence microscope with 63x objective. Confocal images of red fluorescence were 
collected using using 543 mn excitation light from an argon laser and a 560 nm long- 
pass filter; and gieen fluorescence images were collected using 488 mn excitation light 
fr om an argon laser and a 500-550 mn band pass barrier filter.
2.2.4 Western blotting
2.2.4.1 Preparation o f  whole cell lysate
HT-22 cells in 75 cm^  flasks were trypsinised at the indicated time points. The growth 
medium was also collected and spun to recover the cells that had become detached due 
to the treatment. The cells were centrifuged for 3 minutes at 130 x g using a benchtop 
centrifuge. The cells were re-suspended, washed with PBS and lysed by adding 500 pi 
lysis buffer (50mM TrisHCl, 150mM NaCl, 1% Nonidet P40 (NP-40), 0.2% SDS 
solution, 20pM PMSF, Ipg/ml Aprotinin, Ipg/ml Leupeptin, and ImM Na3V0 4 ). A 
further lysing step was performed on the samples by using tip sonicator, holding the 
sample tube in ice following incubation on ice for 20minutes; the samples were spun at 
1000 X g for lOmin at 4°C before being stored at -80°C.
The protein concentration of each sample was deteraiined using BioRad assay. In brief, 
five dilutions of BSA prepared in RO water ranging from 0.2 mg/ml to 1.5 mg/ml were 
used as protein standards and used to plot the standard curve. Aliquots of the cell 
samples were diluted 1:10 and 50pl protein standards and samples dilution were directly 
added to 96-well plate. To each well 25 pi working solution (20 pi reagent S per ml
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reagent A) were added followed by 200 pi of reagent B into each well. Absorbance of 
each well was read at 690 nm.
2.2.4.2 Gel electrophoresis
For gel electrophoresis, 4pi of sample buffer was added to each sample containing 20 or 
50 pg of protein followed by 2pi of reducing agent in a final volume of 22pl. The 
samples were heated at 70°C for 10 minutes and then iimnediately placed on ice for a 
few minutes. Depending on the weight of the protein of interest, Invitrogen NuPAGE 4- 
12% or 10% Bis-Tris gels were used to perform the separation of the proteins. Along 
with pre-stained ladder, 20 pi of each sample were loaded in each well after filling 
Invitrogen Xcell SureLock Mini-cell chamber with NuPAGE® SDS running buffer 
(50ml 20X MOPS and 950ml RO water). The gels were run at 120V for 2 Hours at 
room temperature.
2.2.4.3 Blotting and developing
Following gel electrophoresis, the gel cassette was opened and wells removed with the 
Gel Knife. The gel with activated PDVF membrane in methanol was placed in 
Invitrogen transfer chamber. The inner and outer chamber were filled wiüi transfer 
buffer (50 ml of 20x transfer buffer + 100 ml methanol (per gel) to a final volume of 1 L 
with RO water). The transfer was run at 30 V for 2 Hours.
Once the transfer was done, the membrane was washed twice in 20ml sterile water for 5 
minutes. The membrane was then blocked with 10 ml blocking solution (2ml 
blocker/diluent (Part A), 3ml blocker/diluent (Part B), 3ml RO water, and 0.5g bovine
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serum albumin) for 1 hour on the rotary shaker. Following the blocking step, the 
membrane was incubated over night at 4°c with 10 ml primary antibody diluents 
(primary antibody, 2ml blocker/diluent (Part A), 1ml blocker/diluent (Part B), 3ml RO 
water, and 0.5g bovine semm albumin). The PDVF membrane was washed 3 times 
using 20 ml of antibody wash solutions (10 ml Ab Wash Solution (16x) + 150 ml RO 
water). The membrane was then incubated for 1 hour with a secondary antibody solution 
(Anti-mouse) together with the same preparative ingredients applied in the blocking 
solution, to allow binding of the secondary antibody to the primaiy antibody. To 
develop the protein bands presented on PDVF membrane, Chemiluminescent western 
blot kit immunodetection was used. 2.5 ml Chemiluminescent substrate was applied on 
the membrane surface in dark for 5 minutes to allow the reaction to develop. After 
removing excess Chemiluminescent reagent with filter paper the membrane was covered 
witli sheet of cling film and inserted inside a cassette. A piece of film paper placed on 
top of membrane and cassette closed and secure. The exposure time was ft om 30sec to 2 
minutes depending on the antibody. After the indicated time the films were developed 
and fixed using developing and fixing solutions.
2.2.5 Reverse transcription polymerase chain reaction (RT-PCR) RNA Isolation 
HT-22 cells from 75 cm^  flasks were washed with 3ml PBS, lysed and homogenised 
directly in a culture dish by adding 5 ml of TRIZOL reagent and pipetting several times 
before ti'ansfemng to clean tubes. Insoluble materials were removed firom the 
homogenate by centrifugation at 12,000 x g for 10 minutes at 4°C. The samples were 
incubated for 5 minutes at room temperature then 0.2 ml of chloroform per 1 ml of
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TRIZOL was added and samples shacken vigorously by hand for 15 seconds, following 
incubation at room temperature for 2 to 3 minutes the samples were centrifuged at
12,000 X g for 15 minutes at 4°C. The colourless upper aqueous phase was collected in 
fresh tube (the RNA remains exclusively in the aqueous phase). To precipitate the RNA 
fr om the aqueous phase the samples were mixed with 0.5 ml of isopropyl alcohol per 1 
ml of TRIZOL initially used. The samples were incubated at room temperature for 10 
minutes and then centrifuged at 12,000 x g for 10 minutes at 4°C. The supernatant was 
discarded and the RNA pellets washed once with 1 ml washing solution (75% ethanol in 
RNase-fr ee water) per 1 ml of TRIZOL that initially used. The samples were vortexed 
and centrifuged at 7,500 x g for 10 minutes at 4°C. The RNA pellets were air-diied for 
5-10 minutes, dissolved in RNase-free water and incubated for 10 minutes at 55°C 
before being frozen at -80°C till used. Nano-drop was used to measure the RNA 
concentration in the samples before cDNA synthesis
2.2.5.1 First-Strand cDNA Synthesis
RNA was reverse transcribed to cDNA using Invitrogen kit. The mix was prepared for 
each sample in eppendorf tube on ice containing the followmg, RNA of interest Ipg/ pi, 
10 pi of 2X RT Reaction Mix, 2 pi of RT Enzyme Mix and DEPC-treated water to a 
final volume of 20 pi. The content was mixed gently and incubated at 25°C for 10 
minutes followed by 50 minutes incubation at 42°c. The reaction was teiminated by 
incubation of the tubes at 85 °C at 5 minutes, then chilled on ice. One pi (2 U) of E. coli 
RNase was then added to each tube and incubated at 37°c for 20 minutes. DNA samples 
were stored at -20°C until use.
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2.2.5.2 PCR reaction
The reaction was prepared in 96-well PCR plate. A master reaction mix of common 
components was prepared (25 pi Platinum SYBR Green qPCR SuperMix-UDG, 1 pi of 
10 pM Forward primer of interest, and 1 pi of 10 pM Reverse primer of interest for each 
sample ). Twenty seven pi of master reaction mix was distributed to each well and then 
5 pi of cDNA of interest added. The volume in each well was made up to 50pl using 
DEPC-treated water. The PCR plate was sealed and centrifuged briefly to bring all 
components to the bottom of the plate. Applied Biosystems 7500 Real-Time PCR 
System was used to run the experiment using the following program
Stage Repetitions Temperature Time/minutes
One 1 95.0 °C 10:00
Two 40 95.0 °C 00:30
55.0 °C 00:30
72.0 °C 00:33
Three (Dissociation) , 1 95.0 °C 00:15
60.0 °C 01:00
95.0 °C 00:15
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2o3 Statistical analysis
All data are expressed as means (±SEM) of at least three independent experiments.
Also all the data were involved multiple compression analysed using one-way ANOVA 
followed by Bonfenoni multiple comparisons test (graphpad instat version 11) software. 
Significance difference was set at p< 0.05.
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3 L-glutamate-induced toxicity in HT-22 cell line
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3.1 Overview
In the mature brain, excitotoxicity is thought to be a major contributor to ischaemic 
neuronal cell death via excessive release and activation of L-glutamate receptors 
(Hazell, 2007). Immature neurons may be characterized by a lack of L-glutamate 
receptors and therefore may be resistant to excitotoxicity-mediated cell death (Brewer 
et oA, 2007). However, an alternative non-glutamate receptor mediated oxidative 
neurotoxic pathway has also been described in immature primary neurons (Brewer et 
al., 2007, Ha et al., 2009, Monaghan et al., 1989, Murphy et al., 1990b, Mui*phy and 
Baraban, 1990). The non-glutamate receptor mediated oxidative neurotoxic pathway 
mainly occurs due to the imbalance between biochemical processes leading to the 
production of reactive oxygen species (ROS) and those responsible for the removal of 
ROS. This imbalance in non-glutamate receptor neuron cells has been attributed to the 
breakdown of the L-Glutamate / cystine transporter activity and loss of intracellular 
glutathione (GSH) (Monaghan et a l ,  1989, Schubert and Piasecki, 2001). High levels 
of extracellular L-Glutamate limit or even reverse the cystine / glutamate exchanger 
resulting in reduced cysteine uptake into the cells and ultimately GSH depletion 
(Schubert and Piasecki, 2001).
Under oxidative stress, cells are injured and die by variety of cell death mechanisms. 
Depending on the type and status of the cells, the pattern of cell death can be described 
as apoptosis (Zaman et a l ,  1999), apoptosis-like progiammed cell death (Lang-Rollin 
et al ,  2003, Ziv et al ,  1994), necrosis (Choi K et al ,  2009), or necrosis-like 
programmed cell death (See and Loeffler, 2001). During apoptosis, a series of
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biochemical events proceed in parallel with morphological changes such as cell 
shrinkage, chromatin condensation, DNA fragmentation, phosphatidylserine (PS) 
externalisation and the formation of apoptotic bodies. In contrast, necrotic cell death is 
characterised by loss of membrane integrity, cell and organelle swelling and random 
digestion of DNA. However, studies have also reported that cell death processes can 
occur in apoptosis-like programmed cell death where some of hallmarks of apoptosis, 
such as chromatin condensation and PS externalisation occur but in the absence of 
caspase activation (Lock et al,  2007, Malgorzata et al ,  2008). Other studies have 
described programmed cell death that occurs in the absence of cliromatin condensation, 
PS extemalization, apoptotic body formation, or nuclear fragmentation, but with the 
presence of varying degrees of other apoptotic hallmarks. This latter type of cell death 
is described as necrosis-like progiammed cell death (See and Loeffler, 2001).
Caspases, a family of cysteine-dependent aspartate-dfrected proteases, participate in a 
cascade of morphological and biochemical events leading to apoptotic cell death 
(Kumar, 2006, Lock et al ,  2007, Malgorzata et a l ,  2008). Caspases are present in cells 
as inactive zymogens, organised in a hierarchical manner involving upstream 
initiator caspases and downstream execution caspases. Upon activation of plasma 
membrane death receptors (e.g. CD95) or following selective mitochondiial 
cytochi'ome c release, the apical caspases-8 and -9, respectively become activated and 
in turn activate the execution caspases-3 and -7 by proteolytic cleavage (Kumar, 2006, 
Riedl and Shi, 2004). It has been proven that caspase activation is essential for the
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appearance of classic apoptosis hallmarks such as PS extemalization, apoptotic body 
formation and nuclear fragmentation (Lock et al ,  2007, Malgorzata et al ,  2008).
At high concentrations, L-glutamate causes neurotoxicity via receptor-dependent/- 
independent pathways and is associated with the development of neurodegenerative 
diseases involving oxidative stress. The present chapter aims to employ immortalised 
murine hippocampal HT-22 cells to characterise some of L-glutamate-induced cell 
death featuies through the receptor-independent pathway. Some controversy exists with 
regard to the features of L-glutamate-induced cell death in cultured HT-22 cells. This is 
because previous studies employing caspase inhibitors have provided conflicting 
opinions on the possible roles of caspases in L-Glutamate-induced oxidative 
neuronal cell death. In this chapter, fundamental experiments are conducted to address 
the causal relationship between L-glutamate-induced toxicity and ROS formation, cell 
moiphological changes, PS extemalization and caspase activation.
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3.3 Results
3.3.1 L-glutamate-induced cell death in a time- and -concentration dependent 
manner
It is known that L-glutamate at high concentrations leads to the development of 
certain neurodegenerative diseases. The present results focus on investigating the 
mechanism of L-glutamate-induced cell death in a cultured immortalised mouse 
hippocampal cell HT-22 cell line. Cells treated with 3, 5 or lOmM L-glutamate showed 
time- and concentration-dependent cell death induction as measured by LDH release 
(Figure 3.1). By 8 and 12 hours of L-glutamate treatment at 3 mM concentiations 
(Figure 3.1 A) and 5mM (Figure 3.1 B) respectively, cell death was significant 
compared to LDH release firom control cells. Cell viability reduced markedly to 
approximately 65% and 70% after 24 hours exposure to 3mM and 5mM L-glutamate 
respectively. Dose-response experiments up to lOmM L-glutamate further confirmed 
that L-glutamate reduced the viability of cultured HT-22 cells in a concentration- 
dependent manner (Figure 3.1 C).
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Figure 3.1 L-glutamate induces cell death in a time- and concentration-dependent manner
Cells were exposed to L-glutamate (A: 3mM; B; 5mM) and LDH release was monitored over a 24 hours 
period. In (C) % LDH release from cells incubated with 3, 5 and lOmM L-glutamate for 24 hours is 
plotted. The data represent the mean (n=4 ± SEM) o f four independent experiments. Comparisons o f 
means were made using a one-way ANOVA followed by Bonferroni's post hoc test (* = p < 0.05;*** = p
< 0 .0 0 1 ; ns = not significant).
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3.3.2 L-glutamate induces ROS in a time- and concentration-dependent manner 
Given the critical role of GSH depletion and ROS accumulation in triggering the 
cascade of events leading to the death of HT-22 cells exposed to L-glutamate, the 
change in CM-H2DCFDA oxidation status was caused by intracellular ROS formation 
was monitored to detect and quantify intracellular ROS production. Results 
showed increases in ROS foiination when cells were treated with increasing L- 
glutamate concentrations and also showed that concentrations of ROS were time 
dependent (Figure 3.2 A & B). Intracellular levels of ROS increased by 4% after 4 
hours of treatment with 3 mM L-glutamate (A) from a baseline level of 2 % ROS in 
untreated cells. After 6 hours of heatment, ROS levels increased significantly (p < 
0.001) to reach about 25% of gated cells, reaching a maximum level of approxiruately 
75% after 18 hours treatment.
In figure 3.2 B it is possible to see that ROS production is greater at 5mM doses of L- 
glutamate than at 3mM doses, and that at each dose, ROS accumulation is higher at 18 
hours compared to 8 hours. Interestingly, the length of L-glutamate exposure appears to 
determine the amount of ROS generated than L-glutamate dose. N-acetylcysteine 
(NAG), a precursor of cysteine that can be used by cells for GSH synthesis was used as 
an antioxidant to conftiTU the role of ROS in L-Glutamate-induced cell death in HT-22. 
Both time and concentration dependent ROS formation was prevented by pre-treatment 
with ImM NAG (Figure 3.2 B), maintaining ROS at levels not significantly different to 
control cell levels.
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Figure 3.2 L-glutamate induces ROS production in a time- and concentration-dependent manner
(A) Cells were exposed to 3mM L-glutamate and ROS formation was monitored over a 24 hours period 
by loading cells with CM-H2DCFDA at the time points indicated and measuring DCF fluorescence. In
(B) ROS from cells incubated with 3 and 5mM L-glutamate for 8  or IShours hours was measured using 
the same fluorescence method. 3mM and 5mM L-glutamate conditions at 18 hours were also combined 
with 1 mM NAC treatment to assess antioxidant effect on ROS production. The data represent the mean 
(n=4 ± SEM) o f four independent experiments. Comparisons o f means were made using a one-way 
ANOVA followed by Bonferroni's post hoc test (*** = p < 0.001 ; ns = not significant).
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3.3.3 Morphological changes associated with L-glutamate-induced toxicity
Apoptosis and necrosis are two different forms of cell death whose distinguishing '
characteristics are based largely on morphological features. Classical signs of apoptosis
are characterised by alterations in membrane asymmetry, cell and nuclear shrinkage,
and. chromatin condensation. In contrast, necrotic cell death is characterised by loss of
membrane integidty, cell and organelle swelling and random digestion of DNA. To
define the type of cell death induced in HT-22 cells by L-glutamate treatment,
morphological changes of cells treated with different concentrations of L-glutamate in a ii
Itime course were examined. I
3.3.3.1 L-glutamate-induced toxicity is associated with cell shrinkage and absence o f  \
DNA fragmentation.
Cell shrinlcage or loss of cell volume is typically a major detectable event during 
apoptosis. On the other hand, necrotic cell death is characterized by cell swelling and 
rapid plasma membrane breakdown. The effect of L-glutamate on cell size of HT-22 
cells was therefore measured by confocal microscopy and flow cytometry methods at 
early and late time points, to determine the type of cell death occuning. When cells 
were exposed to L-glutamate for 24 hours, degenerated and rounded cells were clearly 
visible in the culture medium (Figure 3.3).
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Figure 3.3 Confocal Image: L-glutamate treatment induces cell shrinkage
Cells were exposed to either vehicle control (H2O) or 3 mM L-glutamate for 24 hours. Cells were 
exposed to either vehicle control (H2O) or 3 mM L-glutamate for 24 hours. Formaldehyde-fixed cells 
were then viewed using confocal microscopy. Cell shrinkages shown by A
For quantification of cell shrinkage, cells were analysed by flow cytometry using 
forward scatter (FS) and side scatter (SS) measurements. For this analysis, 3, 5 and 
lOmM concentrations of L-glutamate were used. A 0.5mM hydrogen peroxide 
treatment was included as a positive control for oxidative stress and ImM NAC was 
used in combination with 5mM L-glutamate to demonstrate antioxidant effects. Figure
3.4 A shows the flow cytometry output and figure 3.4 B shows the quantitative analysis 
of this image. The quantity of shrunken cells was confirmed by flow cytometric 
analysis as evidenced by a decrease in FS with increasing L-glutamate dose (Figure 
3.4). Figure 3.4 B shows that 40% of HT-22 cells were shrunken after IShours 
treatment with 3mM L-glutamate whereas the number of shrunken cells significantly 
increased to 60% and 80% of total cells after exposure to 5 and lOmM L-glutamate
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respectively. Cell treatment with 0.5mM H2O2 for 18 hours also showed that almost all 
the cells were shrunken whereas NAC completely prevented cell shrinkage induced by 
L-glutamate.
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Figure 3.4 Flow cytometry data: L-glutamate induces cell shrinkage.
HT-22 cells were exposed to H2O (control), 3 mM L-glutamate, 5mM L-glutamate, lOmM L-glutamate, 
0.5mM H2O2 or 5mM L-glutamate with ImM  NAC for 18 Hours. Flow cytometry was used to determine 
forward scatter (FS); high for healthy cells and low for shrunken cells and side scatter (SS); high for 
healthy cells and low for unhealthy cells. (A) Flow cytometry image. (B) Quantitative analysis o f A; each 
bar represents the mean (n=4 ± SEM) o f three independent experiments. Conparisons o f means were 
made using a one-way ANOVA followed by Bonferroni's post hoc test C"* = p <0.01; *** = p < 0.001; 
ns = not significant).
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3.3.3.2 L-glutamate-induced toxicity is not associated with PS externalisation
Phosphatidylserine (PS) under healthy cell conditions is exclusively localised in the 
inner side of the lipid bilayer of the plasma membrane. However, PS externalisation 
occurs due to oxidative disordering of the plasma membrane during apoptosis. 
PS externalisation detection using annexin-V is a widely used method to discriminate 
apoptosis fi*om other types of cell death. The importance of studying PS externalisation 
comes from die fact that PS externalization requires involvement of other apoptosis 
processes such as cytochrome C release and caspase activation (Kagan et al  ^ 2000, 
Lock et al., 2007). Labeling cells with annexin-V and PI easily detects the percentage 
of cells with PS in the outer surface of the membrane using a flow cytometer.
Wlien HT-22 cells were treated with 5 and 10 inM L-glutamate for 8 and 18 hours, the 
number of PI positive cells (D4 quadi ant) increased significantly in a concentration- 
dependent mamier (Figure 3.5; A-F). In comparison, the number of PI and annexin-V 
positive cells in D3 increased relatively slowly compared to the cells in D4. This means 
that the HT-22 cells in D2 have either undergone necrosis, making their membranes 
penetrable for PI and annexin-V or that the HT-22 cells are in the late phase of 
apoptosis. However, early apoptotic cells (PI negative, Annexin V-FITC positive) were 
not present at either 5 or 10 mM L-glutamate treatments, suggesting necrotic cell death. 
In addition, the early time point L-glutamate-treated cells did not associate with PS 
externalisation, further confirming that the cell staining with both PI positive and 
annexin-V positive are not due to late apoptosis (Figure 3.5;G). Treatment with 
0.25mM and 0.5mM H2O2 for 18 hours resulted in almost the same percentage of PI
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and annexin-V positive cells compared to when lOmM L-glutamate was used, whereas 
the percentage of PI only positive cells significantly increased compared to all L- 
glutamate treatments. The percentage of HT-22 cells staining PI and Annexin V-FITC 
positive was the same with lOmM L-glutamate ti eatment as it was when necrotic H2O2 
at 0.5mM was used, indicating that PS externalization is not involved in L-glutamate- 
induced HT-22 cell death.
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Figure 3.5 L-glutamate toxicity does not associated with phosphatidylserine externalization
In the flow cytometry image, HT-22 cells were exposed to either vehicle control H^O (A), 3 mM L- 
glutamate (B), 5mM L-glutamate (C), lOmM L-glutamate (D), 0.25mM H2O2 (E) or 0.5mM H2O2 (F) for 
18 Hours. Cells were harvested and stained with propidium iodide (PI) and Annexin V (AV). Each value 
in the table represents the mean (n=4 ± SEM) o f four independent experiments; D l-4  indicates the 
quadrant on the flow cytometry image. D l = Healthy cells; D2 = Cells conjugated with AV; D3 = Cells 
conjugated with AV and stained with PI; D4 = Cells stained with PI. Conparisons o f means were made 
using a one-way ANOVA followed by Bonferroni's post hoc test (** = p <0.01 ; *** = p < 0.001 ; ns = not 
significant).
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3.3.4 Lack of Caspase-9 activation during L-glutamate-induced toxicity 
A study in our laboratory performed by Dr. L. Elphic showed that HT-22 cell death was 
characterized by cell and nuclear slninkage and cliromatin condensation, but in the 
absence of either DNA fragmentation or mitochondrial cytochrome C release (Elphick 
et al ,  2008). Also, the study found a lack of execution caspase-3 activation in oxidative 
L-glutamate toxicity. To further explore the involvement of the caspase pathway during 
L-glutamate-induced HT-22 cell death, the differential expression of caspase-9 and P53 
mRNAs were analyzed during L-glutamate treatment using Real-Time PGR (RT-PCR) 
(Figure 3.6). The experiment was performed at two different time points (8 & 18 hours) 
using 5mM L-glutamate. RT-PCR amplification of GAPDH was used as a ‘house­
keeping’ gene to normalize mRNA loading and electrophoresis was carried out to 
confirm the absence of contaminating DNA,
6 7
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Figu re 3.6 Analysis o f caspase-9 and P53 mRNA expression by R T-PC R
HT-22 cells were exposed to 5mM L-glutamate for 8  or 18 hours and levels o f  caspase-9 (A) and P53 (B) 
mRNA were determined by RT-PCR. Results were normalised against GAPDH expression and 
compared to expression levels in control cells. Conparisons o f means were made using a one-way 
ANOVA followed by Bonferroni's post hoc test (ns = not significant).
No difference was found in caspase-9, P53 and GAPDH mRNA expression compared 
to control samples. Western blot analysis was performed on cellular extracts prepared 
from HT-22 cells exposed to 5mM L-glutamate for 4, 8, and 18 hours using a P53 
monoclonal antibody (Figure 3.9). Expression of P53 post- glutamate treatment was 
found to be the same as P53 expression in the control samples. Exposure of HT-22 cells 
to UV light confirmed the ability of P53 protein levels to increase in response to stress 
and the lack of a band in the Skov cell line used as a P53 negative control, confirmed 
the specificity of the antibody used. Thus, the consistent results in expression analysis
6 8
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on both mRNA levels and P53 protein levels indicate the absence of caspase-9 
activation by the P53 pathway during the development of L-glutamate-induced cell 
death.
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Figure 3.7 Western blot o f P53 expression in HT-22 cells treated with L-glutamate
P53
GAPDH
Protein was extracted from HT-22 cells after exposure to 3mM or 5mM L-glutamate for 4, 8  or 18 hours. 
Equal protein loading (20pg) per lane was determined using GAPDH expression. As a positive control 
for P53 expression, HT-22 cells were exposed to UV radiation for 4 hours and an increase in P53 was 
observed (lanes 2). As a negative control for P53 monoclonal antibody specificity, protein extracts from 
the the P53 negative Skov cancer cell line were used (lane 3).
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3.3.5 Caspase inhibition enhances L-glutamate induced cytotoxicty through 
increased ROS production 
Inhibition of caspases by the pan-caspase inhibitor Z-VAD-FMK (50 pM) is reported to 
prevent cell death (Stanciu and DeFranco, 2002). However in this study, Z-VAD- 
FMK induced a marked enhancement of 3mM L-glutamate-induced cytotoxicity 
compared to cells treated with 3 mM L-glutamate on its own (Figure 3.8 A; p < 0.001). 
Cell death induced by L-glutamate treatment was prevented by treatment with NAC 
even when Z-VAD-FMK was concomitantly administered. Z-VAD-FMK when dosed 
alone did not induce cell death (A) however; the combination of Z-VAD-FMK plus L- 
glutamate resulted in an increase in the number of shrunken cells that paralleled the 
increase in cytotoxicity (Figure 3.8 B,C & D). Flow cytometric data were confirmed by 
microscopic examination of the cells and it was determined that for each 
treatment, NAC prevented the morphological changes induced by L-glutamate and the 
combination of L-glutamate and Z-VAD-FMK.
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Figure 3.8 L-glutamate-induced cell death is enhanced by Z-VAD-FMK.
Cells were exposed to either vehicle control (H2O) or 3 mM L-glutamate for 16 hours in the absence or 
presence o f Z-VAD-FMK (50 pM) or NAC (1 mM) (alone or in combination) or a corresponding volume 
o f carrier solvent (DMSO). In (A) cells were analysed for cytotoxicity and cell death is expressed as a 
percentage o f total cellular LDH release (n=4 ±  SEM). In (B), the flow cytometry analysis o f cells using 
forward and side scatter parameters a is represented. C. L-glutamate induces cell shrinkage. Cells were 
exposed to vehicle control (H 20) (i), 3 mM L-glutamate (ii), 50 pM Z-VAD-FMK (iii) or 50 pM Z- 
VAD-FMK + 3 mM L-glutamate (iv) for 24 hours. Formaldehyde-fixed cells were then viewed using
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confocal microscopy. In (D), histograms are presented for cells with higli forward scatter (healthy cells) 
and low forward scatter (slirunlcen cells). Each bar represents the mean (n=3 ±  SEM) o f  three 
independent experiments. Comparisons o f means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test (*** = p < 0.001).
Given the critical role of ROS in initiating the cascade of events leading to the death of 
HT-22 cells exposed to L-glutamate, the hypothesis that caspase inliibition would cause 
an exacerbation of ROS production was tested (Figure 3.9). In agreement with the 
earlier findings, 3mM L-glutamate induced a time-dependent increase in ROS 
production as seen by the increased number of cells converting CM-H2DCFDA to its 
oxidised fluorescent DCF product. Incubating HT-22 cells with the pan- 
caspase inhibitor Z-VAD-FMK for over 6 hours did not lead to any detectable changes 
in CM-H2DCFDA oxidation, showing that caspase inhibition by itself did not cause 
any ROS formation.
In clear contrast, the combination of 3 mM L-glutamate with the caspase inliibitor 
resulted in an increase in ROS formation that was significantly higher than in cells 
treated with 3 mM L-glutamate alone (p < 0.05). The effect of these two agents in 
combination had a similar effect on ROS levels as increasing the L-glutamate dose to 
5mM. However, at 5mM L-glutamate treatments Z-VAD-FMK did not significantly 
increase ROS production any further. Nevertheless, these results strongly demonstrate 
that L-glutamate-induced ROS production is enhanced by caspase inhibition, which
could explain the greater magnitude of cell death observed in Figure 3.7 A. Also in
agreement with the previous figure is that a 30min pretreatment of HT-22 cells with the
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anti oxidant NAC (1 mM) completely prevented the increase in ROS formation caused 
by L-glutamate or the combination of L-glutamate and Z-VAD-FMK (Figure 3.9 A).
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Figure 3.9 L-glutamate-induced ROS production is enhanced by Z-VAD-FMK.
Cells were pre-incubated for 30 min with either the pan-caspase inhibitor Z-VAD-FMK (50 pM), NAC 
(1 mM) (alone or in combination) or a corresponding volume o f carrier solvent (DMSO) before exposure 
to L- glutamate (3 mM or 5 mM) for 6  hours and measurement o f DCF formation by flow cytometry. (A) 
Histograms represent DCF formation as measured by flow cytometry. (B) The data represent the mean 
(n=4 ±  SEM) o f four independent experiments. Conparisons o f means were made using a one-way 
ANOVA followed by Bonferroni's post hoc test (** = p < 0.05).
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3.3.6 Autophagy detection with acridiiie orange staining
Autophagy is morphologically characterised by an accumulation of membraneous sacs 
with a double membrane structure, called the autophagosome. Autophagosomes can be 
visualised using acridine orange (AO) that freely crosses biological membranes and 
accumulates in the acidic vesicles associated with autophagic vacuoles where it 
displays considerable red fluorescence. Therefore, AO staining was performed to 
detect whether autophagy was induced in the L-glutamate-treated HT-22 cells (Figure 
3.10).
According to the confocal microscopic observations shown in figure 3.10, the cells in 
the control gioup after AO staining displayed green fluorescence in cytoplasm and 
nucleolus but did not display any red fluorescence. This observation was the same in 
the 5mM L-glutamate-treated cells at 8 and 18 hours. In contrast, prior treatment of HT- 
22 cells with H2O2 showed a considerable amount of bright red florescence upon AO 
staining. Absence of red fluorescence in the L-glutamate-treated cells therefore 
indicates the absence of autophagosome formation. As a further positive control, HT-22 
cells treated with H2O2 were also treated with 5 pM bafllomycin A1 (BAF) for 30 
minutes before the addition of acridine orange. This step was undertaken to inhibit the 
acidification of autophagic vacuoles, and shows that without acidification, no red 
fluorescence is observed.
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Figure 3.10 Assessment of autophagosome formation by acridine orange staining
The images are representative o f typical data obtained using a confocal microscope. HT-22 cells were 
treated with 5 mM L-glutamate ( 8  or 18 hours) or H2O 2 ( 8  hours). Cells were then processed for acridine 
orange staining as described in the materials and methods section. As a positive control, HT-22 cells 
treated with H2O 2 were treated with 5pM bafllomycin A1 (BAF) for 30 minutes before the addition o f 
acridine orange to inhibit the acidiflcation o f autophagic vacuoles.
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Flow cytometiic results (Figure 3.11) then confirmed the aforementioned observations 
in Figure 3.9 and allowed stain quantification. As before, AO was not detectable in 
contr ol and HT-22 L-glutamate-treated cells after 8 or 18 hours treatment. In contrast, 
HiOi-treated cells showed a significant (p < 0.001) increase in AO staining compared 
to both L-glutamate-ti'eated HT-22 cells and the cells loaded with H2O2 and 5 pM BAF 
for 30 minutes before the addition of acridine orange.
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Figure 3.11 Quantification of acridine orange staining in HT-22 cells using flow cytometr)
Cells were treated with either 5mM L-glutamate (8 o rl8  hours) or H2O 2 (8 hours), harvested and 
processed for acridine orange (AO) staining as described in the materials and methods. As a positive 
control, HT22 cells treated with H2O2 were treated with 5 pM bafllomycin A1 (BAF) for 30 minutes 
before the addition o f AO to inhibit the acidification o f autophagic vacuoles. (A) Sarrples were then 
analysed using flow cytometric analysis o f acridine orange stained cells at 630 nm for red fluorescence 
and at 525 nm for green fluorescence. (B) The data represent the mean (n=4 ± SEM) o f four independent 
experiments. Conparisons o f means were made using a one-way ANOVA followed by Bonferroni's post 
hoc test (*** = p < 0.001, ns = not significant).
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3.3.7 Protective effects of Nec-1 on L-glutamate-induced HT-22 cell death 
Recently, a caspase-independent cell death pathway that results in morphological 
features resembling necrosis was identified by Degterev et ah (2005) and termed 
’Necroptosis’. In the experiment presented below, necrostatin-1 (Nec-1) was used as an 
inhibitor of necroptosis to determine whether this pathway was involved in L- 
glutamate-induced HT-22 cell death. As seen in figure 3.12, Nec-1 induced dose- 
dependent cell protection when dosed in combination with 3 and 5mM L- glutamate. 
The combination of Nec-1 plus L-glutamate resulted in a marked decrease in the 
number of slirunlcen cells that reflected the decrease in cytotoxicity (data not shown). 
10 pM doses of Nec-1 caused insignificant cell death when used alone, showing LDH 
levels comparable with control cells. When 10 pM was used in combination with 3mM 
L-glutamate, cell death was approximately reduced by 50% compared to L-glutamate 
only treatment. Increasing concentrations of Nec-1 at either 3 or 5mM L-glutamate 
doses afforded dose-dependent cytoprotection to HT-22 cells.
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Figure 3.12 The effects of Nec-1 on L-glutamate-induced HT-22 cell death.
Cells were pre-incubated for 30 min with Nec-1 (10, 25, and 50 pM) before exposure to L-glutamate 
(3 mM or 5 mM) for 16 hours and measurement o f LDH release. Cell death is expressed as a percentage 
o f total cellular LDH release, with each bar representing the mean (n=4 ± SEM) o f  four independent 
experiments. Coirparisons o f means were made using a one-way ANOVA followed by Bonferroni's post 
hoc test.
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3,4 Discussion
Oxidative L-glutamate toxicity in HT-22 murine hippocampal cells is a model for 
neuronal death by oxidative stress via a receptor-independent pathway (Maher and 
Davis, 1996, Tan et a l,  1998b). The consensus in the literature is that the main cause of 
oxidative L-glutamate toxicity in HT-22 cells is attributed to the breakdown of the L- 
glutamate / cystine tiansporter and loss of intracellular glutathione (GSH) (Philipp et 
al,  2010, Tan et a l,  1998a). However, it still debated whether L-glutamate-induced cell 
death in cultured HT-22 cells is mediated via apoptosis, necrosis, or a new form of cell 
death. In agreement with earlier studies (Tan et a l,  1998a, Noh et a l,  2006 and Ha and 
Park, 2006), 3 mM L-glutamate induced a time-dependent increase in ROS production 
as shown by the increased number of cells that had converted CM-H2DCFDA to its 
oxidised fluorescent DCF product.
The gradual increase of ROS after L-glutamate tieatment is mainly attributed to the 
steady drop in glutathione levels (Tan et a l,  1998a). High levels of extracellular L- 
glutamate causing limited or even reversal of the cystine / L-glutamate exchanger 
results in prevention of cysteine uptake into the cells and ultimately causes GSH 
depletion (Philipp et al, 2010). GSH helps to protect cells from ROS and detoxifies 
endobiotic and xenobiotic electrophiles (Li, 2009). GSH is located mainly in the 
cytosol, nucleus and mitochondria and it is considered significant for protecting the 
organelle from ROS produced during coupled mitochondrial electron transport and 
oxidative phosphorylation (Li, 2009).
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The ability to distinguish the type of cell death still depends primarily on the 
morphological changes that occur during the process. Therefore, to determine whether 
the HT-22 cells response to L-glutamate challenge was apoptosis or another type of cell 
death experiments were carried out to detect hallmarks that distinguish apoptosis from 
other types of cell death. A morphological experiment using flow cytometry confiiined 
HT-22 cell shrinkage that is a common feature of apoptosis. Nevertheless, Annexin V 
results showed that L-glutamate mainly induces necrotic cell death and a moderate 
percentage of late-stage apoptotic cell death. This observation was clarified by the fact 
that HT-22 cell death induced by L-glutamate did not involve externalisation of 
phosphatidylserine to the outer leaflet of the plasma membrane.
The most likely reason for the incomplete hallmarks of apoptosis is the lack of 
cytoclirome C release and execution caspase activation. The role of caspases in 
externalisation of phosphatidylserine has been confirmed in many studies using the 
pan-caspase inhibitor Z-VAD-FMK that has been shown to significantly inhibit 
phosphatidylserine externalisation but not membrane blebbing. Tliis finding is also 
compatible with an early finding in our laboratory that showed that HT-22 cell death is 
also characterised by distinct clu'omatin condensation, but without DNA fragmentation 
or cytoclirome C release. Absence of apoptotic body formation and nuclear 
fiagmentation mainly occurs when caspases are not activated (El-Hassan et al, 
2003 and Bezvenyuk et al, 2003), are inhibited (Johnson et a l,  2000) or are not 
expressed (Zheng et a l,  1998).
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Initial studies testing pan-caspase inhibition in L-glutamate-induced cell death revealed 
protective effects against L-glutamate toxicity (Stanciu and DeFranco, 2002). However, 
this study and other later studies have found that Z-VAD-FMK significantly enhanced 
L-glutamate-induced cell death; an effect that was, at least partly, reproduced by 
inhibiting the initiation caspases-8 and -9 (Elphick et a l,  2008). The ability of Z-VAD- 
FMK to enhance cell death has previously been observed in tumor necrosis factor- 
and ROS-mediated cell death models (Cauwels et al, 2003, Kim and Park, 2003, Liu et 
al, 2003, Martinet et a l,  2006, May and Madge, 2007, Prabhakaran et al, 2004, 
Uchiyama et a l, 2007, Vercammen et a l,  1998). It is noteworthy that in these 
studies, caspase inhibition led to a switch from apoptosis to necrosis. In addition, L929 
mouse fibrosarcoma cells (Yu et a l ,  2006) and murine embryonic fibroblasts (May and 
Madge, 2007), respond to Z-VAD-FMK with enhanced ROS formation. In L929 cells, 
this was attributed to catalase degiadation with downstream activation of autophagic 
cell death (Yu et a l, 2006). The consequences of caspase inhibition are very much 
different fr'om what is reported herein. Z-VAD-FMK did not cause an increase 
in ROS formation in the absence of L-glutamate and did not induce a switch in the type 
of cell death. Instead, the enhanced execution of cell death was along the same pathway 
tiTggered by L-glutamate with no apparent morphological or biochemical difference.
Recently, it has been reported that the inhibition of caspase-9 in lymphoblastic cells, 
whether by LEHD-FMK or by RNA interference-mediated caspase-9 down-regulation, 
led to an increase in apoptosis (rather than a switch to necrosis) in response to trophic 
signal removal and staurosporine (Shah et a l ,  2004). Likewise, caspase-8 activation is
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now recognised to play an important role in B-cell survival (Dolu'man et al, 2005, 
Lemmers et a l,  2007). Therefore, an additional role for caspases (and in particular 
initiation caspases) appears to exist that counteracts HT22 cell death. The molecular 
mechanism underlying this caspase-mediated effect appeared to be linked to the level 
of ROS production. As reported here, even though Z-VAD-FMK by itself had no effect 
on basal ROS production, when combined with L-glutamate, the levels 
of ROS produced were approximately doubled. Therefore, L-glutamate-induced 
toxicity involves increased cytotoxic ROS production that is accelerated 
by caspase inhibition. We propose that initiation caspases limit ROS production by L- 
glutamate but that the target protein involved remains to be identified. It has been 
suggested that caspase-mediated cleavage of ROS-generating proteins, such 
as receptor-interacting protein (RIP) and phospholipase A%, may constitute a potential 
mechanism (Cauwels et al, 2003, Chipuk and Green, 2005).
Caspase-independent cell death has been reported in a spectrum of cells exposed to 
sti'ess conditions, such as oxidative stress, starvation or ischemia/reperfusion (Matsui et 
al,  2007, Rosenbaum et al., 2010, Chen et al, 2007, Scherz-Shouval et a l,  2007). ROS 
generating agents (e.g. H2O2) can also induce autophagic cell death in a caspase- 
independent manner (Scherz-Shouval et al,  2007). In addition, autophagic caspase- 
independent cell death is reported to be induced tlirough an increase of ROS production 
resulting fiom caspase blocking (Yu et a l ,  2006). However, autophagosomes were 
undetectable in L-glutamate-induced oxidative stress in HT-22 cells, indicating the 
absence of an autophagic cell death pathway. An alternative possibility was identified
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when Nec-1 rescued HT-22 cells from L-glutamate-induced cell death, suggesting that 
cell death was mediated tlirough necroptosis machinery (Degterev et a l, 2008, 
Vandenabeele et a l ,  2010b, Zhu a/., 2011).
Earlier studies showed that the protective effects of Nec-1 in HT-22 cells involves an 
increase in cellular GSH levels as well as a reduction in ROS production (Xu et al, 
2007). However, Nec-1 did not protect HT-22 cells against hydrogen peroxide induced 
cell death, suggesting that Nec-1 has no antioxidant effects in these cells. In addition, 
Nec-1 has been shown to rescue HT-22 cells even when cellular GSH was depleted (Xu 
et a l,  2007). The protective effect of Nec-1 has recently been reported to be mediated 
by its ability to block the kinase activity of receptor interacting protein 1 (RIPl), which 
is an essential component of the necroptosis pathway (Degterev et a l, 2008, 
Vandenabeele et a l, 2010b, Zhu et al, 2011). In further studies, inhibition of RIPl 
activity via Nec-1 efficiently inhibited necroptosis in an immortalised stiatal cell line 
(ST 14A) and in an R6/2 tiansgenic mouse model of Huntington’s disease (Zhu et al, 
2011). These reports provide support to the premise that Nec-1 mediated its protective 
effect on HT-22 cells via inhibition of fundamental components in the necroptosis 
pathway.
3,5 Conclusion
HT-22 cells died via a form of progiammed cell death that is similar to, but distinct 
from, classical apoptosis and necrosis. This cell death is characterised by cell shrinkage, 
yet occurs in the absence of membrane asymmetry, DNA fragmentation, mitochondiial
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cytochrome C release, and caspase activation. This study provides support to the 
premise that L-Glutamate-induced cell death occurs via necroptosis pathway.
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Mitochondria have vital multiple functions in the cell including amino acid 
biosynthesis, fatty acid oxidation steroid metabolism and maintenance of the cellular 
energy reserves via ATP production through the electron transport chain. 
Nevertheless, mitochondria are known to be a significant source of superoxide 
radicals and other ROS that are associated with oxidative stress (Malinska et a l,  
Mathisen et a l ,  2007). Mitochondria also play an essential role in intracellular 
Ca^  ^regulation, and the triggering of apoptosis. ROS produced by mitochondria 
could be derived from electrons leaking from the transport chain to oxygen at sites o f  
high oxygen potential. Under normal conditions it is thought that 1% of  
mitochondrial electron flow contributes to the formation of superoxide radicals (02  ') 
(Klein and Ackerman, 2003) . Respiratory chain activity leads to the production of 
quinones and semi-quinones that are believed to be the main factor contributing to 
increased oxidative stress at complexes I and III (Drechsel and Patel, 2008). 
Mitochondrial damage is associated with many neurodegenerative diseases (Lin and 
Beal, 2006). Mitochondrial related diseases are assumed to be due to an increase in 
intracellular oxidative stress generated as a byproduct o f oxidative phosphoiylation 
(Boneh, 2006). Despite the fact that electron transport is a highly efficient system, 
superoxide can be released at different locations along the electron transport 
chain under normal physiological conditions (Liu and Schubert, 2009). The 
superoxide anion, which is unable to leave the matrix, can either act within 
the mitochondria as a signaling molecule or alternatively convert to hydrogen 
peroxide, which is able to traverse from the inner mitochondrial membrane
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through aquaporin-like channels, thus influencing events in the cytosol (Busija et al. 
2008).
4,2 Chapter ah
L-glutamate induces ROS production in HT-22 cells due to limiting or even 
reversing the action of a cystine /L-glutamate exchanger (Tan et a l,  1998a). 
However, many studies have demonstrated that the drop in glutathione level 
observed upon L-glutamate treatment was not sufficient on its own to account for the 
elevatation in the amount of ROS. Therefore, this leads to the theoiy that other 
sources of ROS production may be involved in L-glutamate-induced cell death. This 
chapter sets to examine the role of mitochondria in HT-22 cell death in response to 
L-glutamate injury. To investigate mitochondrial functions, the roles of 
mitochondrial membrane potential (MMP: AT^ m) and the mitochondrial permeability 
transition pore (MPTP) were evaluated using the fluorescent TMRE probe. In 
addition, the induction of mitochondrial reactive oxygen species (mtROS) was tested 
using the mitochondrial-specific ROS probe MitoSox.
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4.3 Results
4.3.1 Mitochondrial dysfunction in L-glutamate-induced HT-22 neurotoxicity 
Previous work within this laboratory has shown that L-glutamate-induced HT-22 cell 
death occurs in the absence of cytochrome C release or caspase activation (Elphick 
et ah, 2008). However, these two observations do not rule out a role of mitochondria 
in L-glutamate-induced HT-22 cells death. In the following experiments, a TMRE 
fluorescent probe was used to measure A'Fm and to determine the effect of L- 
glutamate treatement on this parameter. TMRE dye accumulation by mitochondria is 
proportional to AYm; where the greater AYm polarisation, the more TMRE dye is 
accumulated in the matrix of mitochondria. As a positive contol, the mitochondrial 
uncoupler, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) that causes 
mitochondria membrane depolarisation was applied to HT-22 cells 3 minutes prior 
to TMRE loading (Figure 4.1 A).
The results of this experiment showed that HT-22 cells treated for IShours with 3 or 
5rnM L-glutamate treatment underwent significant dose-dependant decreases in 
ATm (Figure 4.1 B). Approximately 30% and 50% of the gated HT-22 cells did not 
accumulate TMRE after IBHours of exposure to 3 and 5mM L-glutamate 
respectively. Mitochondrial membrane depolarisation was confirmed to prevent 
TMRE accumulation in the mitochondrial matrix, where 70% of the gated HT-22 
cells failed to accumulate TMRE when cells were preloaded with CCCP.
8 9
C h a p te r  4: R o l e  o f  m it o c h o n d r ia  in  L -g l u t a m a t e - in d l c e d  t o x ic it y  in  H T -2 2  c e l l  l in e s
B
5lU
■TMRE
Conkol
CCCPamMglutointe
SmMglulMnIe
lOOi
<  40-.c.5»JZ
£  20-
0)O
ns
Figure 4.1 Response o f TMRE fluorescence to mitochondrial depolarisation by L-glutamate.
HT-22 cells were incubated at 37°C with either 3 or 5mM L-glutamate for 18 hours. Cells were 
loaded with lOOnM TMRE probe for 40min as described in the materials and methods chapter. 
Positive control cells were incubated with CCCP at room tenperature for 3min prior loading with 
TMRE. (A) Represent histograms corresponding to mitochondrial membrane depolarisation in HT-22 
cells undergoing L-glutam ate-induced cell injury in the presence o f  3 and 5 mM glutamate compared 
to and the positive control treatment CCCP and untreated control cells. (B) Data represents the mean 
(n=4 ± SEM) o f  four independent A'Pm experiments in HT-22 cells treated with L-glutamate (3 & 
5mM) for 18Hours and then stained with TM RE as described in the materials and methods sections. 
Corqparisons o f  means were made using a one-w ay ANOVA followed by Bonferroni's post hoc test 
(** = p < 0.05 and *** = p < 0.001 control versus L-glutamate treatment; ns = not significant).
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4.3.2 Role of the mitochondrial permeability transition pore in L-glutamate- 
induced HT-22 neurotoxicity 
The mitochondrial permeability transition pore (MPTP); a non-selective inner 
membrane permeabilisation marker, is considered a key factor in the damage of 
neurons by excitotoxicity. To examine whether MPTP contributed to the cascade 
events in non-glutamate receptor oxidative damage in HT-22 cells, the effects o f  
cyclosporin A (CsA); a MPTP blocker, was tested. As shown in Figure 4.2, IpM 
CsA protected HT-22 cells from the collapse of ATm. HT-22 cells treated with 3 or 5 
mM L-glutamate for ISHours maintaned their A'Pm when they were pre-incubated 
with IpM CsA prior to L-glutamate treatment, showing significant (p < 0.05) 
differences in TMRE retention when compared to when L-glutamate was used alone 
(Figure 4.2 C). The inclusion of the CCCP positive control shows that cells 
responded to treatment and that treatment with L-glutamate caused a dose-dependent 
reduction of TMRE fluorescence in the absence of CsA.
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Figure 4.2 The effect o f Cyclosporin A on TM RE fluorescence in L-glutam ate-induced  
mitochondrial membrane depolarised cells
HT-22 cells were incubated at 37°C with either 3 (A) or 5mM L-glutamate (B) for 18Hours in the 
presence or absence o f  IpM  CsA. Cells were loaded with lOOnM TMRE probe for 40min as 
described in the materials and methods section. Positive control cells were incubated with CCCP 
at room  tenperature for 3 min prior loading with TM RE as further control for A'Pm depletion. (C) The 
data represent the mean (n=4 ± SEM ) o f  four independent A'Pm experiments as shown in A and B. 
Corrparisons o f  means were made using a one-w ay ANOVA followed by Bonferroni's post hoc test 
(*** = p < 0.001 versus L-glutamate treatment).
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In parallel with CsA protection from AYm collapse, LDH data showed that CsA 
significantly (p < 0.001) promoted cell survival when HT-22 cells were treated with 
3 or 5mM L-glutamate for ISHours in the presence of IpM CsA (Figure 4.3). L- 
glutamate treatment alone however induced dose-dependent cell death.
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Figure 4.3 The effect o f Cyclosporin A on cell death in L-glutam ate-induced mitochondrial 
membrane depolarised cells
HT-22 cells were incubated at 37°C with either 3 or 5mM L-glutamate for ISHours in the presence or 
absence o f  1 pM  CsA then LDH release measured as described in the materials and methods section. 
The data represent the mean (n=4 ±  SEM ) o f  four independent LDH experiments. Comparisons o f 
means were made using a one-way ANOVA followed by Bonferroni's post hoc test (*** = p < 0.001 
versus L-glutamate treatment).
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4.3.3 Role of calcium in L-glutamate-induced HT22 cell death via ROS 
production
Since both influx of and ROS production initiate MPTP opening and promote 
cell death, the role of Ca^ "^  in L-glutamate-induced HT-22 cytotoxicity was 
investigated. In this investigation, ROS and LDH levels were monitored as shown in 
figure 4.4. Buffering of intracellular Ca^ "^  achieved by pre-loading the HT-22 cells 
with 20 pM BAPTA-AM for 30 min significantly suppressed L-glutamate- 
induced cell death (Figure 4.4 A). B APT A itself induced moderate cytotoxicity; 
however, this was significantly less than the toxicity caused by L-glutamate alone. 
Importantly, L-glutamate did not further enhance the toxicity of B APT A as LDH 
levels released upon B APTA-L-glutamate combination treatment were lower. Also, 
the results showed that when the cells were treated in the presence of calcium- 
modulating BAPTA (20pM), the production of intracellular ROS induced by L- 
glutamate was effectively prevented (Figure 4.4 B). In contrast, the production of 
intracellular ROS remained elevated in cells treated with 5mM L-glutamate, as 
indicated using DCF formation as an end point. The previous data suggest that a 
Ca^ "^  mediated increase of ROS was sequentially involved in L-glutamate-induce 
oxidative HT-22 cell death.
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Figure 4.4 L-glutam ate-induced cytotoxicity and ROS production are inhibited by cytosolic 
Ca^ +
Cells were exposed to 5mM L-glutam ate for 24 h in the absence or presence o f  20 pM BAPTA, a 
cytosolic Ca^^ buffering agent. Data represents the mean (n=4 ± SEM ) o f  four independent 
experiments o f  HT-22 cells. (A) Cell death as a percentage o f  cellular LDH release. (B) Cells were 
loaded with CM -H 2DCFDA followed by DCF fluorescence measurement as described in the materials 
and methods section. Comparisons o f  means were made using a one-w ay ANOVA followed by 
Bonferroni's post hoc test (*** = p < 0.001 versus L-glutamate treatment).
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4.3.4 L-glutamate-induced mitochondrial ROS (mtROS)
43.4,1 Live-cell bioimaging using the fluorescent probes MitoSOX and CM-
H2DCFDA
To localise the source of ROS produced by L-glutamate treatment, intracellular 
bioimages of ROS generation using the fluorescent dyes, MitoSox red mitochondrial 
superoxide indicator and CM-H2DCFDA indicator were compared. Mitosox is a 
highly selective dye that detects mitochondrial superoxide but not other ROS or 
reactive nitrogen species (RNS), whereas H2DCFDA is a general cytosolic ROS 
indicator, detecting mainly hydrogen peroxide. Compared to control sample images 
(Figure 4.5), each stain individually showed clear fluorescence around the nucleus 
with a few fluorescence foci in the cytosol when the HT-22 cells were treated with 3 
or 5 mM L-glutamate for 8 and IShours. In addition, MitoSox probe foci were also 
noticed inside the nucleus when HT-22 cells probed with MitoSox in the L- 
glutamate-treated cells but not in control cells. Double staining using MitoSox (Red 
fluorescence) and H2DCFDA (Green fluorescence) showed that the gi'een and red 
fluorescence were co-localised, appearing as yellow in the composed images.
These images indicate that the major source of intiacellular ROS upon exposure of 
HT-22 cells to 3 and 5 mM L-glutamate for 8 and 18 hours was the mitochondria. 
The antioxidant NAC at a concentration of ImM, significantly suppressed 
fluorescence intensity o f H2DCFDA and prevented cell slirinkage in L-glutamate 
treated cells. However, NAC did not prevent the MitoSox fluorescent intensity when 
cells exposed to L-glutamate treatment, suggesting that NAC might not be effective 
at reducing mtROS production.
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Figure 4.5 Live im aging o f HT-22 cells using MitoSox or DCF DA stains for ROS
Cells were exposed to L-glutamate (3 or 5mM) in absence or presence o f  NAC (1 mM) and then 
loaded with CM -H 2 DCFDA and M itoSox at 8 or 18Hours followed by fluorescence imaging as 
described in the materials and methods section.
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43.4.2 Flow cytometric detection o f  fluorescence MitoSOX and CM-H2DCFDA 
probes
To confirm the aforementioned bioimage observations (Figure 4.6) indicating that 
ROS production occurs mostly in the mitochondria, flow cytometric analysis of HT- 
22 cells was used. Flow cytometry is a much more sensitive technique, providing a 
clearer quantitative representation of ROS status after L-glutamate tieatment. The 
subsequent analysis confirmed that L-glutamate did indeed induce a time- and 
concentration- dependent increase in the fluorescent products of MitoSox and CM- 
H2DCFDA oxidation (Figure 4.6). The 8 hours time point showed that the 
percentage of cells gated with MitoSox fluorescence (Figure 4.6 B) was almost 
double the percentage of cells gated with DCF (Figure 4.6 A) fluorescence for both 3 
and 5 mM L-glutamate treatments. These results indicate that oxidative stress in the 
mitochondria could be a critical early event ultimately resulting in cell death.
After 18 hours exposure to 3 and 5 mM L-glutamate, both Mitosox and CM- 
H2DCFDA oxidised fluorescent products had reached comparable levels with only 
moderate increase in the levels of MitoSox at 5mM L-glutamate (Figure 4.6 B & D). 
The results also showed that the production of ROS in the mitochondria and the 
cytosol was considerably higher m the cells treated with 5mM L-glutamate 
compared to the cells treated with 3mM L-glutamate at 8hr treatment.
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Figure 4.6 L-glutam ate-induced ROS and mtROS production in HT-22 Cells.
HT-22 cells were exposed to L-glutamate (3 or 5mM) in the absence or presence o f  NAC (1 mM) and 
then loaded with CM -H 2D CFDA  or M itoSox stains at SHours or 1 SHours. CM -H 2DCFDA (A & B) 
and M itosox (C & D) oxidised products were measured using fluorescence flow cytometry as 
described in the materials and methods section. Each bar represents the mean (n=4 ± SEM) o f  four 
independent experiments. Com parisons o f means were made using a one-w ay ANOVA followed by 
Bonferroni's post hoc test (*** = p < 0.001 versus L-glutamate treatment).
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4.3.5 Mitochondria reactive oxygen species sources in L-glutamate-induced 
toxicity
The previous section demonsti'ated that L-glutamate causes an increase in the 
generation of ROS at the mitochondiial level. It is believed that these ROS then enter 
the cytosol and initiate signaling pathways leading to cell death. Therefore, to 
confirm the connection between L-glutamate, mtROS and cellular redox status, HT- 
22 cells were pre-treated with selective compounds prior to L-glutamate treatment. 
These substances specifically inhibited ROS species formation, providing 
information about the mitochondrial sources of ROS.
4,3.5.1 Effect o f  DPI on mitochondria-derived superoxide and L-glutamate- 
induced HT-22 cytotoxicity
Diphenylene iodonium (DPI) abrogates mitochondrial ROS generation by inhibiting 
electron transport at the flavin site in mitochondrial Complex I, in particular by 
inhibition of NADPH oxidase (Tammariello et a l,  2000). Although DPI was 
expected to decrease the cellular generation of ROS, the flowcytometric results 
showed significant stimulation of ROS generation by DPI in both control cells and 
those ti*eated with L-glutamate (Figure 4.7). Significant increases in Mitosox and 
CM-H2DCFDA fluorescence levels were observed in HT-22 cells treated with DPI at 
early and late time points (8, 18 hours). The generation of ROS in HT-22 cells 
treated with DPI on its own was markedly higher than in the control cells and the 
cells treated with 3 or 5mM L-glutamate. Although these results appeared to exclude 
the role of NADPH oxidase in L-glutamate-induced ROS, the parallel increase in 
both Mitosox (C & D) and CM-H2 DCFDA (A & B), especially when cells were
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treated with DPI alone, support the proposal that the source of ROS in L-glutamate- 
treated cells is the mitochondria. Increased levels of ROS when cells were loaded 
with DPI could be attributed to a DPI-induced decrease in the cellular content of 
GSH, which is the primary cause of L-glutamate-induced cell death (Riganti et al., 
2004).
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Figure 4.7 The role of DPI in L-glutam ate-induced ROS and mtROS production in HT-22 Cells.
HT-22 cells were exposed to L-glutamate (3 or 5mM) in the absence or presence o f  DPI (lO pM ) and 
then loaded with CM-H^DCFDA or M itoSox stains at SHours or 1 SHours. CM -H 2DCFDA (A & B) 
and M itosox (C & D) oxidised products were measured using fluorescence flow  cytometry as 
described in the materials and methods section. Each bar represents the mean (n=4 ± SEM ) o f  four 
independent experiments. Comparisons o f  means were made using a one-w ay ANOVA followed by 
Bonferroni's post hoc test (*= p < 0.05; ** = p < 0.01 ; *** = p < 0.001 ; ns = not significant).
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Despite the increase in the ROS levels caused by DPI treatment of HT-22 cells 
(Figure 4.7) the results of an LDH experiment indicated a significant decrease of 
lactate dehydrogenase leakage into the extracellular medium (Figure 4.8). It thus 
appears that DPI reduces L-glutamate-induced cell death, despite increasing levels of 
ROS.
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Figure 4.8 The role o f DPI in L-glutam ate-induced cytotoxicity o f HT-22 Cells.
HT-22 cells were exposed to L-glutamate (3 or 5mM) in the absence or presence o f  DPI (lOpM ). L- 
glutamate-induced HT-22 cell death is expressed as a percentage o f  total cellular LDH release 
measured as described in the materials and methods section. Each bar represents the mean (n=4 
±  SEM) o f four independent experiments. C onparisons o f means were made using a one-way 
ANOVA followed by Bonferroni's post hoc test (*** = p < 0.001 versus L-glutamate treatment).
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4.3.6 Effect of NDGA on mitochondria-derived superoxide and L-glutamate- 
induced HT-22 cytotoxicity
To investigate whether lipoxygenase (LOX) activation is involved in L-glutamate- 
induced H-22 cell death, nordihydroguaiaretic acid (NDGA) was used as a LOX 
inhibitor. Pre-treatment of HT-22 cells with 0.5pM NDGA completely prevented 
LDH leakage in the presence of 3 and 5mM L-glutamate (Figure 4.9). Cell death 
decreased from 50% and 70% in the 3 and 5mM L-glutamate treatment respectively 
to 7% in the presence of NDGA after 18 Hours.
80
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Figure 4.9 The role o f NDGA in L-glutamate-induced cytotoxicity o f HT-22 Cells.
HT-22 cells were exposed to L-glutamate (3 or 5mM) in the absence or presence o f  ND GA  (0.5pM ). 
L-glutamate-induced HT-22 cell death is expressed as a percentage o f  total cellular LDH release 
measured as described in the materials and methods section. Each bar represents the mean (n=4 
± SEM ) o f four independent experiments. Comparisons o f  means were made using a one-way 
ANOVA followed by Bonferroni's post hoc test (*** = p < 0.001 versus L-glutamate treatment).
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In parallel to the effect of NDGA on cell viability, its effect on the ROS levels in 
HT-22 cells was also examined. At the early time point o f treatment (8 hours), 
0.5pM NDGA was able to prevent the mtROS elevation caused by 3 and 5mM L- 
glutamate (Figure 4.10 C). In contrast, at the same time point, it is clear that NDGA 
was not able to significantly prevent general intracellular ROS elevation as shown by 
DCF staining (B). DCFDA results showed that intracellular ROS formation by L- 
glutamate in the presence of NDGA was L-glutamate dose-dependant. Wlien 3mM 
L-glutamate was used alone, almost 60% of gated cells were Mitosox fluorescent- 
positive, compared to over 60% at a 5mM L-glutamate dose. 0.5 pM NDGA reduced 
Mitosox-positive cells to approximately 10% of the population in both cases. At late 
time point (18 hours), NDGA significantly reduced the levels of mtROS and general 
intracellular ROS to levels below those caused by 3 and 5mM L-glutamate treatment 
alone (Figure 4.9 BD) This indicates that reductions of intracellular ROS as a result 
of NDGA treatment may only be observed at later time points, whereas mtROS 
reduction can be detected earlier. At both early and late time points, reductions of 
mtROS after L-glutamate treatment were of greater magnitude than general ROS 
reductions.
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Figure 4.10 The role o f lipoxygenase in L-glutam ate-induced ROS and mtROS production in 
HT-22 Cells.
HT-22 cells were exposed to L-glutamate (3 or 5mM) in the absence or presence o f DPI (0.5pM ) and 
then loaded with CM -H 2 DCFDA or M itoSox stains at SHours or 1 SHours. CM -H 2DCFDA (A & B) 
and M itosox (C & D) oxidised products were measured using flow cytometry as described in the 
materials and methods section. Each bar represents the mean (n=4 ±  SEM ) o f four independent 
experiments. Comparisons o f  means were made using a one-w ay ANOVA followed by Bonferroni's 
post hoc test (* = p< 0.05; ** = p < 0.01; *** = p < 0.001 versus L-glutamate treatment; ns = not 
significant).
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4.4 Discussion
Reduction of cellular GSH levels intiates the cascade events in non-glutamate 
receptor neuronal cells but the sites of ROS production are not yet clear. The present 
study aimed to investigate mitochondrial processes as contributing factors in L- 
glutamate-induced cell death via oxidative stress in HT-22 mouse hippocampal 
neuronal cells. Early studies showed that cerebellar granule cells underwent either 
apoptosis or necrosis depending on the L-glutamate concentration, but most 
importantly depending on mitochondrial dysfunction (Giordano et al., 2007). 
Neuronal cells may also undergo early necrotic cell death due to the ATm collapse, 
whereas viable cells survive with relatively intact mitochondria and undergo 
apoptosis at late time points (Buckman and Reynolds, 2001, Giordano et a l,  2007, 
Kang et a l ,  2007). However, in HT-22 cells under our experimental conditions, cell 
death resembled neither apoptosis nor necrosis in response to L-glutamate insults but 
instead displayed some morphological features of both types of cell death (Elphick et 
a/., 2008).
HT-22 A'Fni experimental results showed that AT^ m collapse was involved in L- 
glutamate-induced HT-22 cell death as L-glutamate-treated HT-22 cells showed 
significant and dose-dependant A'Pm collapse. These observations, combined with 
the previous observations that L-glutamate induces ROS in a dose-dependant 
manner, could reflect the correlation between degree of A'Pm reduction and ROS 
levels in the cells, which ultimately causes cell death. Under oxidative stress 
conditions, the A'Pm collapse occurs due to the opening of MPTP (Rosenstock et a l , 
2004, Tmshina and McMurray, 2007). The Immunosuppressant CsA prevents A'Pm 
reduction by binding to Cyclophilin-D and blocks its translocation to the inner
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mitochondrial membrane (Hansson et a l ,  2003). Lack of Ppif; the gene that encodes 
Cyclophilin-D, results in protection of cells from necrotic and caspase- 
independent cell death (Baines et a l ,  2005, Basso et a l,  2005, Naga et a l,  2007). In 
addition to its immunosuppressant properties, research has also shown that CsA has 
an inhibitoiy effect on Cyclophilin-D, thereby blocking mitochondrial calcium efflux 
(Bambrick et a l ,  2006). Therefore, the observed protection of HT-22 cells by CsA 
from L-glutamate-induced cell death seen in this study suggests that the MPT pore is 
important in the cell death pathway activated by L-glutamate.
An increase in Ca^  ^levels in HT-22 cells exposed to L-glutamate has been 
previously documented (Herrera et a l ,  2007, Tan et a l ,  1998a). Previous 
experiments in our laboratory have also shown that in the absence of extracellular 
Ca^ ,^ L-glutamate-induced HT-22 cell death is significantly suppressed (Elphick et 
al,  2008). The calcium results presented herein showed that chelating Ca^  ^ with 
BAPTA prevented both ROS formation and cell death in L-glutamate-treated HT-22 
cells. This suggests that an increase in the intracellular Ca^ "^  levels is not only 
responsible for L-glutamate-induced cell death (Elphick et a l,  2008), but it also 
involves a ROS-generator. In addition, the role of extracelluar Ca^ "^  influx was 
previously reported to cause an increase in ROS in HT-22 cells (Ha and Park, 2006). 
Moreover, MPTP pores have been found to play an important physiological role in 
helping the mitochondiia to buffer intracellular Ca^ "^ , which is determining factor in 
neuronal death (Azarashvili et a l ,  2010). On the other hand, ROS generation 
promotes Ca^  ^ release from mitochondrial matrix and therefore enlrances the 
probability of MPTP opening (Weiss et a l ,  2003). The data presented in tliis chapter 
strongly suggest that Ca^  ^influx, intracelluar Ca^ ,^ and MPTP all play a role in ROS 
production and L-glutamate-induced cell death. Furthermore, preventing ROS
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formation by blocking or chelating Ca^ "^  indicates that GSH depletion is not the only 
the cause of intracelluar ROS elevation.
The results of the MitoSox experiment confirm the involvement of mtROS in HT -22 
L-glutamate-induced cell injury. Different possible ROS-generating sites in the 
mitochondrial electron transport chain (ETC) exist that can produce mtROS in cells 
(Busija et a l ,  2008, Liu and Schubert, 2009). Complex I in the mitochondrial ETC 
has been shown to generate mtROS in neurodegenerative diseases through inhibition 
of forward election transfer or with reverse electron transfer (Liu and Schubert, 
2009). It has also recently been reported that mtROS production caused by complex I 
inhibition involves flavin mononucleotide (FMN) (Taylor et a l ,  2003). In addition, 
tln*ee ubiquinone-binding sites in complexes I, II and III have been found to be 
responsible for mtROS production (Liu and Schubert, 2009).
The present data showed that inhibition of fiavoenzymes using DPI did not reduce 
the mtROS or ROS, but instead caused significant increases in mtROS. However, 
these results do not exclude a role of fiavoenzymes in mtROS production, where DPI 
is reported to inhibit cell redox metabolism and induces oxidative stress tlirough 
depletion of GSH (Riganti et a l ,  2004). In addition, it is been reported that DPI was 
able to prevent mtROS elevation in HT-22 cells when used at low concentrations 
(nM) rather than being used in the pM range (Liu and Schubert, 2009). However 
even in the nM range, DPI on its own caused an increase in mtROS (171%) and 
intracelluar ROS (150%) compared to control samples (Liu and Schubert, 2009). 
Despite DPI increasing ROS, DPI protects cells fi-om L-glutamate-induced cell death 
possible as a result of DPI-mediated cell cycle arrest (Scaife, 2004) (Please see 
chapter5).
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It is been established that L-glutamate causes glutathione depletion in HT-22 cells by 
limiting or even reversing the action of a cystine /L-glutamate exchanger (Murphy et 
aL, 1990a). Reduced glutathione levels trigger 12/15-LOX that ultimately mediates 
neuronal toxicity (Jin et a l,  2008, Wang et a l ,  2004). In addition, the cytotoxicity o f  
oligodendroglial and brain endothelial cells is mediated by 12/15-LOX (Jin et a l ,  
2008, Wang et a l ,  2004). Mitochondria are vulnerable to 12/15-LOX effects that 
cause mitochondrial membrane depolarisation and ROS formation (Pallast et a l,  
2009). In agreement with the previous study, NDGA, a general LOX inhibitor, 
protected the cell against L-glutamate injury and suppressed cell death. Moreover, 
NDGA treatment significantly reduced mtROS levels suggesting that LOX interacts 
with mitochondria and causes the elevation of mtROS in HT22 cells.
Conclusion
GSH depletion initiate building up of ROS but it is not the only cause of ROS 
accumulation; MPT pores have shown an important physiological role in L- 
glutamate-induced HT-22 cell death involving mtROS production and A'Pm 
depletion. In addition, LOX is potential source of mtROS induced due to L- 
glutamate injury.
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5oi Overview
Wlien neurons leave the ventricular zone and the sub-ventricular zone, they become 
terminally differentiated and ineversibly withdraw from the cell cycle. However, a 
substantial body of evidence links the failure of cell cycle regulation in post mitotic 
neurons to neuronal cell death pathways that lead to several neurodegenerative 
disorders (Greene et a l ,  2007, Majd et a l ,  2008). Experimentally, initiation of the 
cell cycle in mature neurons leads to cell death instead of cell division, whereas 
blocking the cell cycle leads to rescue of the cells (Liu et a l ,  2010). In addition, re­
expression and activation of the cell cycle has been observed in Alzheimer disease 
(AD) neurons that undergo apoptosis post cell cycle re-entry (Bonda et a l,  2009). 
Cyclins, CDKs and other cell cycle regulators are expressed in the AD brain. G1 
progression of AD neurons is consistent with the expression of late G1 markers, 
cyclin E and CDK2 (Nagy, 1997). Yang et a l  (2001) have found that AD neurons 
duplicate their genome prior to their death.
Various damaging stimuli such as excitotoxicity and toxic concentrations of
amyloid-P can drive cell cycle re-expression and cell death in cultured CNS neurons
(Lee et a l,  2010). The cell cycle regulator including cyclins have also been shown to
mediate neuronal apoptosis in cases of cell exposure to toxic stimuli such as 13-
amyloid. Studies have shown increase in the levels of Cyclin D and E following
treatment of cerebellar granule neurons with different stimuli (Copani et a l ,  1999,
Pavlova et a l,  2006, Rideout et a l ,  2003). This finding has been confirmed in an in
vivo excitotoxicity model, where cyclin D and CDK4 are up-regulated in apoptotic
brain areas following kainic acid treatment (Ino and Chiba, 2001). Therefore, G1
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regulators have been proposed to contribute to excitotoxicity-induced brain damage 
in vivo (Copani et a l ,  1999). Other studies also report S phase entry and DNA 
replication in neurons prior to apoptosis when cells are exposed to neurotoxic 
stimuli,whereas DNA replication is absent in models of naturally occurring neuronal 
apoptosis (Becker and Bonni, 2004).
5.2 Chapter Aim
As demonstrated in the previous chapters, the L-glutamate-treated HT22 neuronal 
cells die in response to oxidative stress conditions. However, the molecular 
mechanism by which oxidative stress causes neuronal cell death still needs to be 
investigated. One of the mechanisms linked to oxidative neurodegeneration is 
aberrant re-entry into the cell cycle. In this chapter, experiments were designed to 
test the hypothesis that there is a casual link between L-glutamate-induced cell death 
in HT-22 cells and the cell cycle. HT-22 cells are immortalised cells proliferate 
under normal cell growing conditions. Hence, the aim of the first set o f experiments 
was to examine the effect o f L-glutamate on HT-22 cell cycle and cell cycle 
regulators. To test the ability o f L-glutamate to induce cell cycle activation, HT-22 
cell cycles were synchronised using either serum starvation methods or chemicals to 
aiTest the cell cycle in a given phase. Once the cells were syncbionised, the effect of 
L-glutamate was investigated firstly in cells arrested in different stages of the cell 
cycle and secondly, following release o f the cells into the cell cycle.
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5,5 Results
5.3.1 Effects of L-glutamate on the HT-22 cell cycle
The purpose of this investigation was to test the hypothesis that cell cycle activation 
plays a role in the mechanism of L-glutamate-induced HT-22 cell death. First, the 
effect o f L-glutamate treatment on HT-22 cell cycle was investigated using flow 
cytometric analysis. Dose-response studies o f the effect of L-glutamate (3 and 5 mM) 
at different time points (8, 12, 18 and 24 hours) were carried out to examine the 
effect on the cell cycle by means of propidium iodide (PI) staining (Figure 5.1 A & 
B). Propidium iodide is a typical cell cycle stain able to pass tlirough permeabilised 
cell membrane and intercalate into cellular DNA.The intensity of the PI signal is 
directly proportional to DNA content. As a positive control, apoptosis was initiated 
by staurosporine, which is known to block the cell cycle at the S/G2 phase (Figure
5.1 B). Figure 5.1 C shows the results of the four independent cell cycle experiments, 
carried out as described above.
The results show that 2pM staurosporine caused an increase in the number of HT -22 
cells in G2 phase after 12 hours by 10% compared to control cells and ultimately 
caused G2/M phase arrest (Figure 5.1 B). In contrast, treatment with L-glutamate at 3 
and 5 mM had no effect on the percentage of cells in G2 or Gl/S phases, with 
proportions remaining similar those observed in control cells (Figure 5.1 C: G2 
-11%; Gl/S -47%). The effect o f L-glutamate treatment was consistent across all 
time points measured (Figure 5.1 C).
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Figure 5.1 Cell cycle distribution o f HT-22 cells in the presence o f L-glutam ate using PI staining.
HT-22 cells were exposed to L-glutamate (3 and 5mM) and fixed in 70% ethanol at the indicated tim e 
po ints (8 , 12, 18 ,24 Hours), followed by staining with lOpl o f 1 mg/ml PI stock (see materials and 
methods). (A) H istograms corresponding to the cell cycle distribution o f L-glutam ate-induced cell 
death at different time points (8,12,18, 24 Hours) for cells treated with 0.5m l milli Q water (contol), 
3mM L-glutamate, or 5mM L-glutamate. H istograms were analysed using ‘M ulticycle for W indows’ 
software, with the addition o f  IpM  staurosporine used as a positive control for apoptosis, using PI 
staining at 12 hours (B). F low cytom etry results o f  four independent HT-22 cell cycle experiments 
(mean ±  SEM) carried out using the same control and treatment conditions are shown in (C).
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Further confirmation for the aforementioned results came from the data obtained 
from bromodeoxyuridine (BrdU) incorporation that was used as an another approach 
to determine cell cycle phase changes as result of L-glutamate-induced HT-22 cells 
injury at different time points. BrdU incoiporate into newly synthesised DNA when 
the cell is dividing, particularly in the DNA synthesis phase of cell cycle (S Phase). 
Specific anti-BrdU fluorescent antibodies were used to measure the levels of cell- 
associated with BrdU by flow cytometiy. Figure 5.2 shows that treatment with L- 
glutamate at 5 mM at different time points (8, 12, 18 and 24 hours) had no effect on 
the percentage of cells in Gl/S or G2 phases, with proportions remaining similar to 
those observed in control. The effect of L-glutamate treatment was also consistent 
across all time points measured (Figure 5.1 C).
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Figure 5.2 Cell cycle distribution o f HT-22 cells in the presence o f L-glutam ate using BrdU  
incorporation
HT-22 cells were exposed to 0.5m l milli Q water (contol) or 5mM L-glutamate and fixed in 70% 
ethanol at the indicated time points (8 , 12, 18, 24 Hours). Cells were then stained using the BrdU 
incorporation method (see materials and methods) and identified by flow cytometry.
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5.3.2 Effect of cell cycle arrest on L-glutamate-induced cell death
5,3,2.1 Arresting HT-22 cells at the GO/Gl phase \
HT-22 cells are immortalised cells that proliferate under basal cell growing 
conditions. To investigate the effect of L-glutamate on HT-22 cell cycle profile, HT- ;
22 cells were growth-aixested the GO/Gl phase using the serum deprivation method.
HT-22 cells were cultured in 0.2%, 2% and 10% FBS culture conditions for 48 hours i
I
prior the treatment with 5 mM L-glutamate to assess cell cycle stage and 3 and 10 
mM L-glutamate to assess LDH release (Figure 5.3 A & B respectively). Following 
serum deprivation, 63% and 55% of HT-22 cells were arrested in GO/Gl phase in 
response to 0.2% and 2% FBS, respectively (Figure 5.3 A). In contrast, GO/Gl phase 
contained 45% of unarrested cells when treated with 10% FBS (Fig 5.3 A).
Treatment with 5mM L-glutamate did not cause any detectable changes in the HT-22 
cell cycle profile under serum deprivation conditions (Fig5.3 A). However, the 
decrease in FBS concentiation significantly increased the number of viable HT-22 
cells following L-glutamate treatment (Figure 5.3 B). Cell death declined from 30% 
when cells treated with 3mM L-glutamate in complete growing medium (10% FBS) 
to approximately 5% under serum deprivation conditions for 18 hours. The same 
results were obtained when cells were tr eated with a high concentration of L- 
glutamate (lOmM), where the number of dead HT-22 cells significantly dropped 
from 70% in cells cultured in complete medium to only 35% and 15% when cells 
were treated in medium with 0.2% and 2% FBS respectively. Serum deprivation did 
not cause any toxicity as measured by LDH release from cells not treated with L- 
glutamate (Figure 5.3 B).
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Figure 5.3 Effect o f cell cycle arrest in GO/Gl phase on L-glutam ate-induced HT-22 cell death.
HT-22 Cells were seeded either in corrp lelete medium  with 10% o f FBS, 2% FBS or 0.2% FBS as 
indicated on the graphs. Cells were then exposed to L-glutamate (5 mM) and fixed in 70%  ethanol 
followed by staining with lOpl o f Img/ml PI stock as described in the materials and methods. (A) 
H istograms represent the HT-22 cell cycle corresponding to L-glutamate-induced cell death after 
18Hours o f  treatment. Control cells were treated with with 0.5 ml milli Q water and seeded at the 
concentrations o f  FBS indicated. Test cells were treated with 5mM L-glutam ate for 24 hours and 
seeded at the FBS concentrations shown. (B) The data represents the mean (n=4 ± SEM) o f four 
independent LDH experiments using HT-22 cells treated with 3 and lOmM L-glutamate for ISHours 
in medium with 0.2%, 2% FBS or 10% FBS. Comparisons o f means were made using a one-way 
ANOVA followed by Bonferroni's post hoc test (*** = p <  0.001; ns = not significant vs glutamte 
treatment).
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53,2.2 Arresting HT-22 cells in the G2/Mphase
The previous experiments showed that arresting the cell cycle in GO/Gl by serum 
deprivation promoted HT-22 cell suiwival. Therefore, the role of Nocodozol; a 
known G2/M cell cycle arresting agent was investigated by monitoring cell cycle 
profiles and LDH levels in the presence of L-glutamate. As shown in Figure 5.4, pre- 
loading the cells with 50, 100 and 500 nM Nocodozol notably arrested the cells in 
G2/M phase in normal and L-glutamate-treated cells (Figure 5.4 A). Nocodozol itself 
induced moderate cytotoxicity (Figure 5.4.B), however, Nocozodol produced a 
cytoprotective effect when used in combination with L-glutamate, which had the 
largest toxic effect. Importantly, Nocodozol treatment significantly raised cell 
survival in presence of L-glutamate treatment. Compared to the 35% and 50% cell 
death levels observed due to 3 and 5mM L-glutamate treatment respectively, only 
20% and 30% of cells died when ti eated concomitantly with 500nM Nocodozol.
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Figure 5.4 Effect of cycle arrest in G2/M  phase on L-glutam ate-induced HT-22 cell death.
HT-22 Cells were seeded in complelete medium with 10% o f FBS in the presence or absence o f 
Nocodozol (0, 50, 100 or 500nM ) as indicated in the graphs. Cells were then exposed to L- 
glutamate (3 and 5mM) for 24Hours and fixed in 70% ethanol followed by staining with lOpl o f  
1 mg/ml PI stock as described in the materials and methods. (A) H istograms represent the HT-22 cell 
cycle corresponding to L-glutamate-induced cell death after 24Hours treatment. Control cells were 
treated with with 0.5 ml milli Q water and seeded at the concentrations o f Nocodozol indicated. Test 
cells were treated with 5mM L-glutamate for 24 hours and seeded at the Nocodozol concentrations 
shown. (B) The data represents the mean (n=4 ±  SEM ) o f four independent LDH experiments using 
HT-22 cells treated with 3 and lOmM L-glutamate for 24 Hours in medium with 50, 100 or 500nM 
Nocodozol. C onparisons o f  means were made using a one-way ANOVA followed by Bonferroni's 
post hoc test (* = p < 0.05; *** = p < 0.001 ; ns = not significant).
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5.3.3 L-gîutamate-induced HT-22 cell cycle progression
T o evaluate if  L-glutamate caused progression of the cell cycle in HT-22 cells, the 
fluorescent tracers, carboxyfluorescein diacetate (CFSE) and succinimidyl ester 
(CFSE) were used to see if they could help to identify the stage of the cell cycle 
during which cell death occurred. CFSE was expected to show whether HT22 cells 
died prior or post cell division after L-glutamate insult. Once CFSE gets inside the 
cell, the succinimidyl ester in CFSE binds to intracellular amines, particularly to the 
amine groups of proteins. During each round of cell division, CFSE divides equally 
between the daughter cells, thus reducing the fluorescence intensity in the daughter 
cells by half. The difference in fluorescence intensity between the cells can easily be 
detected by flow cytometry making it possible to discriminate between daughter and 
parent cells.
Unfortunately, CFSE did not perform as expected as the flow cytometry histograms 
produced only one peak instead of multiple peaks, indicating that all of the HT-22 
cells contained the same amount of CFSE. The most probable reason for this peak 
separation problem could be attributed to the rationale that CFSE is usually used to 
track cell division in fast dividing cells, such as Human peripheral blood 
lymphocytes, while the HT-22 cells divide slowly under normal conditions (roughly 
2 divisions per 48 hours). However CFSE worked in terms of the intensity of the 
stain, which reduced over time (Figure 5.5). This showed that the majority of HT22 
cells had divided at least once more than control cells during 24 hours of L-glutamate 
treatment. These results therefore suggest the L-glutamate accelerates the cell cycle 
and ultimately causes HT-22 cell death.
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Figure 5.5 Tracking o f HT-22 cell division using CFSE.
HT-22 cells were loaded with CFSE probe as described in the materials and methods section. HT-22 
cells were seeded in conp le te  medium with 10% o f  FBS in the presence or absence o f 3 and 5mM L- 
glutamate for 24Hours followed by flow cytom etry analysis. The graph represents the shift observed 
in HT-22 cell fluorescence due to decrease in CFSE intensity following L-glutam ate-induced cell 
death after 24Hours treatment (control untreated) cells; solid green line, 3mM  L-glutam ate-treated 
cells; dotted blue line, 5 mM L-glutam ate-treated cells; dotted red line, unstained HT-22 cells; dotted 
black line).
According to the LDH data showed previously, L-glutamate caused ~ 40 to 50% cell 
death at 24Hours in the L-glutamate treated cells comparing to ~4% in untreated 
cells. To confirm whether the decrease in CFSE intensity in the L-glutamate-treated 
HT-22 cells was related to the rate of cell division and not fluorescence loss due to 
death, HT-22 cells were re-analysed using flow cytometry in the presence of CFSE 
and 7-AAD probes (Figure 5.6 A B & C). The 7-AAD probe enabled four distinct 
HT-22 populations to be distinguished:
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Cells stained CFSE positive and 7 -AAD negative indicate viable cells (quadrant (Q) 
4 in Figure 5.6 A, B & C).Cells both stained CFSE and 7-AAD positive indicate 
injured cells (Q2 in Figure 5.6 B & C).Cells stained 7-AAD positive and CFSE 
negative indicated dead cells that either lost or remained unstained with the CFSE 
(Q1 in Figure 5.6 C).Cells both stained CFSE and 7-AAD negative indicated viable 
cells that remained unstained (Q3 in Figure 5.6 A, B &C).
The data showed that the majority of dead cells stained positive with 7-AAD were 
also CFSE positive, suggesting that the injured HT-22 cells did not lose the CFSE 
stain (Figure 5,6 D). In summary, the majority of cells contained CFSE in L- 
glutamate treated and non-treated HT-22 populations, however the intensity of CFSE 
in the treated cells was considerably less than the intensity in the non-treated cells. 
Since the decrease in the CFSE intensity is not related to cell death, the reduction of 
CFSE intensity measured can be attributed to L-glutamate-induced cell division.
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Figure 5.6 Tracking o f HT-22 cell division and viability using CFSE and 7-AAD
HT-22 cells were analysed by flow  cytom etry in the presence o f CFSE and 7-AAD probes to assess 
whether CFSE is lost due to cell death or cell division. HT-22 cells were loaded with CFSE and 7- 
AAD probes as described in the materials and methods section. HT-22 cells were seeded in 
complelete medium with 10% o f  FBS in the presence or absence o f  3 and 5mM L-glutamate for 
24Hours followed by flow cytometry analysis. (A) control cells with 0.5ml milli Q water (B) 3mM L- 
g lutamate (C) 5mM L-glutamate. Q l:  Cells with 7-AAD positive and CFSE negative staining 
representing dead cells that either lost the CFSE or remained unstained; Q2: Cells stained both CFSE 
and 7-AAD positive, representing injured cells; Q3: Cells with both CFSE and 7-AAD negative 
staining, representing viable cells that rem ained unstained; Q4: Cells stained CFSE positive and 7- 
AAD negative, representing viable cells. (D) The data represent is the mean (n=4 ± SEM) o f  four 
independent experiments to assess the total fluorescence in HT-22 cells treated with L-glutamate at 
either 3 or 5mM for 24Hours, in the presence or absence o f  CFSE stain. Comparisons o f  means were 
made using a one-way ANOVA followed by Bonferroni's post hoc test (ns = not significant).
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5.3.4 Re-entry of arrested HT-22 cells into the cell cycle provokes L - 
glutamate-induced cell death 
The previous sections have shown that cell cycle aiTest prevents L-glutamate- 
induced cell death. Next it was important to test the hypothesis that releasing cells 
fi'om cell cycle anest would lead to L-glutamate-induced cell death. To achieve this, 
HT-22 cells were arrested either by serum deprivation or by treatment with 
Nocodozol for 24Hours, and then released from either condition for the following 
24Hours. The effect of L-glutamate on cell viability was monitored continuously 
over the two-phase 48 Hr period. In the first 24 Hours, cells were cultured in the 
absence or presence of L-glutamate (3 and 5mM), and in the second 24 Hours 
medium was either replaced with new complete growth medium (10% FBS) or 
Nocodozol was removed from the growth medium. In the case of HT -22 cells 
blocked in GO/Gl phase, the serum-deprived growth medium was replaced with 
complete growth medium prior L-glutamate treatment.
Figure 5.7 A shows that cells were released from cell cycle arrest by treatment with 
10% FBS post 24 Hours of cell cycle arrest in 0.2% FBS medium. Following cell 
cycle release, the percentage of cell death increased significantly in the next 24 hours 
in L-glutamate treated cells to reach about 60% for 5mM L-glutamate (Figure 5.7B). 
Cells still cell cycle-arrested however, showed little response to L-glutamate 
treatment and showed similar death rates to those receiving complete medium in the 
absence of L-glutamate (conti'ol).
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Figure 5.7 Effect o f L-glutam ate treatm ent on cell cycle block/release using serum deprivation.
(A) H istograms represent the DNA content o f  HT-22 cells seeded either in medium with 0.2%  FBS 
or in com lete medium (10% FBS) for 24 Hours. Both groups were treated with 5mM L-glutam ate for 
24 Hours followed by medium replacement with fresh complete m edium containing 5mM L- 
glutamate. HT-22 cells were fixed in 70% ethanol after a total o f 48Hours, followed by staining with 
lOpl o f  1 mg/ml PI stock as described in the materials and methods chapter. (B) The data represents 
the mean (n=4 ± SEM) o f  four independent LDH experiments using HT-22 cells grown in the 
presence or absence o f  L-glutam ate for 48Hours and in either 0.2% or 10% FBS medium. 
Comparisons o f means were made to 24 hours L-glutamate-treated cells with 0.2%  FBS using a one­
way ANOVA followed by Bonferroni's post hoc test (*** = p < 0.001; ns = not significant).
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The results obtained using the semm deprivation method in Figure 5.7, were 
reproducible when the cell cycle was arrested by Nocodozol treatment (50, 100, & 
500 nM) then released by Nocodozol removal (Figure 5.8). These results show that 
cell cycle blocking by a range of Nocodozol concentrations was able to protect the 
cells from L-glutamate challenge. L-glutamate treatment alone caused the largest 
amount of cell death, followed by the condition where Nocodozol was removed after 
24 hours. Cell death can be seen to increase sharply after 24 hours immediately after 
Nocodozol removal, causing 80% cell death. Nocodozol treatment on it is own 
produced dose-dependent toxicity, however Nocodozol was significantly less toxic 
than the toxicity caused by L-glutamate in presence of Nocodozol or when L- 
glutamate was used alone.
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Figure 5.8 Effect o f L-glutamate treatm ent on cell cycle block/release using Nocodozol.
The data represented are the mean (n=4 ±  SEM ) o f  four independent LDH experiments using HT-22 
cells treated with 3mM L-glutamate or 5mM L-glutamate (columns) for 48 Hours. For the first 24 
Hours, cells were incubated with L-glutamate in 10% FBS medium in the abscenee (control untreated 
& gluatamte conditions only) or presence o f  50, 100 nM Nocodozol or 500 nM  Nocodozol (rows) for 
48 hours. In the L-glutamate plus Nocodozol for 24 Hr group, medium containing Nocodozol was 
removed and replaced with N ocodozol-ffee complete media and 3 or 5mM L-glutamate after 24 
Hours. C onparisons o f means were made to 24 hours L-glutamate-treated cells in precence o f  
Nocodozol using a one-way ANOVA followed by Bonferroni's post hoc test (** = p < 0.01;
*** = p < 0 .0 0 1 ).
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5.3.5 Role of jun N-terminal Kinase (JNK) in L-glutamate-induced cell death 
The following study was conducted to investigate the possible role of MAP kinases 
in protecting HT-22 cells from L-glutamate-induced cell death through cell cycle 
regulation. As shown in frgure 5.9 A, when the JNK inhibitor was present in cell 
culture, it was able to protect HT-22 cells against L-glutamate insults. Cell death 
dropped significantly from 50% and 70% when cells were tieated with 3 and 5mM 
L-glutamate for 18 Hours to 20% and 30% respectively when the JNK inhibitor was 
also included. The results also show that the JNK inhibitor alone did not affect cell 
viability. Analysing the cell cycle in the presence or absence of the JNK inliibitor 
using PI staining revealed that HT-22 cells were anested at G2/M phase when 
inhibitor was present (Figure 5.9 B). Thus, treatment with JNK inhibitor causes cell 
arrest in the G2/M phase and therefore protects from L-glutamate insults.
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Figure 5.9 The role o f a JNK inhibitor in L-glutam ate-induced cell death.
(A) LDH release: Each bar represents the mean (n=4 ± SEM) o f  four independent LDH experiments 
from HT-22 cells treated for ISHours with 3 and 5mM L-glutamate post 30min loading with lOpM 
JNK inhbitor. (B) H istograms represent cell cycle histogram o f HT-22 cells seeded in conp le te  
m edium (10% FBS) for 18 Hours with (+JNK  inhbitor) or without (-JNK inhbitor). HT-22 cells were 
fixed in 70% ethanol after 18 Hours followed by staining with PI stain as described in the materials 
and methods section. Com parisons o f  means were made using a one-w ay ANOVA followed by 
Bonferroni's post hoc test (*** = p < 0.001; ns =  not significant).
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5.5.5.i Is the protective effect o f  JNK inhibition mediated via reduction o f  EOS?
T o test the effect a JNK inhibitor on the ROS status in HT-22 cells, CM-H2DCFDA 
and Mitosox stains were used to track the level o f general intracellular and 
mitochondrial ROS respectively. The number of DCF and oxidised Mitosox 
fluorescent-positive cells resulting from 8 and 18 hours of 3 and 5mM L-glutamate 
treatment are shown in figure 5.10. CM-H2 DCFDA staining (A & B) showed that 
JNK inliibition sigificantly increased ROS in combination with 3mM L-glutamate 
after 8 hours (A) and increased ROS due to 3 and 5mM L-glutamate at 18 hours (B). 
At 18 hours, ROS exceeded 70% when either concentration of L-glutamate was used, 
regardless of JNK inhibitor action. The JNK inhibitor itself was also shown to reduce 
ROS at 18 hours (B).
Mitosox staining (Figure 5.10 C & D), yielded similar yet more pronounced results at 
8 hours. The JNK inhibitor caused significant increases in mtROS at 3 and 5 mM 
concentrations of L-glutamate (C). However, at 18 hours Mitosox staining did not 
detect any significant increases in mtROS due to JNK inhibition at either L- 
glutamate dose (B). JNK inhibitor alone did not produce significant mtROS at 8 
hours, but did increase them at 18 hours. Therefore, it would appear that the 
protective effects of the JNK inhibitor observed previously are not mediated via 
prevention of ROS production and suggests that L-glutamate-induced oxidative 
stress is not the only cause of cell death.
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Figure 5.10 The Role o f JNK inhibitors on ROS production in L-glutamate treated cells.
HT-22 cells were exposed to L-glutamate (3 & 5 mM) in presence or absence o f  a JN K  inhibitor and 
then loaded with CM -H 2DCFDA or M itosox stains at 8  Hours or 18 Hours. CM -H^DCFDA (A & B) 
and M itosox (C & D) oxidised products were measured using fluorescence flow cytometry as 
described in the materials and methods section. Cells were pre-incubated for 30 min with JN K  
inhibitor (10 pM), and an equal volume o f  carrier solvent (M e2 S0 ) was added to controls before 
exposure to L-glutamate and measurement. Each bar in the figure represents the mean (n=4 ±  SEM) o f 
four independent experiments. Com parisons o f  means were made using a one-w ay ANOVA followed 
by Bonferroni's post hoc test (* = p < 0.05; *** = p < 0.001; ns = not significant).
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5.3.6 The protective role of protein synthesis inhibition in L-glutamate- 
induced HT22 cell death 
Recent studies have shown that treatment with cyclohexamide (CHX) prevents 
glutathione decrease and therefore ROS accumulation (Castagne and Clarke, 1997). 
This effect indicates the important role of de novo protein synthesis in cells 
undergoing ROS-induced cell death. To address the connection between de novo 
protein synthesis in L-glutamate-tieated cells, mitochondrial ROS, cellular redox 
induction and cell cycle phase, HT22 cells were exposed to 2.5 pg/ml CHX and then 
exposed to 3 or 5 mM L-glutamate for 8 or 18 Hours. Figure 5.11 
Figure 5.11 shows that CHX caused inhibition of both the early (8 hour) and late (18 
hour) ROS bursts that occurred due to L-glutamate treatment. This inhibition of ROS 
formation was observed at the level of both general intiacellular ROS (A & B) and 
mitochondrial ROS formation (C & D). The percentage of HT-22 cells gated with 
CM-H2 DCFDA fluorescence was approximately 9% when CHX was included with 3 
and 5 mM L-glutamate treatments, which was similar to the percentage of control 
cells (4%) gated at 8 hours (A). At 18 hours (B), intracellular ROS levels in the CHX 
treated cells were slightly higher than in controls, but significantly lower than ROS 
levels in cells treated with L-glutamate but not CHX. Mitosox staining (C & D) 
showed that mitochondrial ROS levels did not increase significantly above control 
levels when CHX was used in combination with L-glutamate at either concentration. 
This effect was observed at both 8 hours (C) and 18hours (D), whereas L-glutamate 
treatment alone caused >60% cell death at 3mM and >80% cell death at 5mM after 
24 hours of treatment.
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Figure 5.11 The role o f CHX on ROS production in L-glutamate treated cells.
HT-22 cells were exposed to L-glutamate (3 & 5 mM) in presence o r absence o f  2.5pg/m l 
cyclohexamide (CHX) and then loaded with CM -H 2DCFDA or M itosox stains at 8 Hours or 18 
Hours. CM -H 2DCFDA (A & B) and M itosox (C & D) oxidised products were measured using 
fluorescence flow cytometry as described in the materials and methods section. Cells were pre- 
incubated for 30 min with CHX (2.5 pg/m l), and an equal volume o f  carrier solvent (M e2 SO) was 
added to controls before exposure to L-glutamate and measurement Each bar in the figure represents 
the mean (n=4 ± SEM) o f  four independent experiments. Comparisons o f means were made using a 
one-way ANOVA followed by Bonferroni's post hoc test (** = p < 0 .0 1 ; *** = p < 0.001; ns = not 
significant).
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The LDH data in figure 5.12 (A), shows that CHX provides full protection to HT-22 
cells against L-glutamate challenge. Therefore, it appears that inliibition of protein 
synthesis by CHX had potent antioxidant effects on the ROS levels caused by L-
glutamate treatment. The protective effects o f CXH on L-glutamate-treated cells also 
included a Gl-S cell cycle arrest (Figure 5.12 (B)). Cell cycle analysis showed that 
CHX treatment caused an increase in the HT-22 population existing in the Gl-S  
phase (68%) compared to control cells without CHX (47%).
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Figure 5.12 The role CHX on cell death in L-glutam ate treated cells.
(A) LDH release: Each bar represents the mean (n=4 ± SEM) o f four independent LDH 
experiments from HT-22 cells treated for ISHours with 3 or 5mM L-glutamate post 30min 
loading with o f 2.5 pg/m l CHX.. (B) Histograms represent the DNA content o f  HT-22 cells 
seeded in complete m edium (10%) FBS with or without (control) 2.5pg/ml CHX. HT-22 cells 
were fixed in 70% ethanol followed by staining with lOpl o f  1 mg/ml PI stock as described in 
the materials and methods chapter. C onparisons o f means were made using a one-way ANOVA 
followed by Bonferroni's post hoc test (*** = p < 0.001; ns = not significant).
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5.4 Discussion
Neurons are terminally differentiated in the healthy mature brain, meaning that they 
should not undergo further progression. Accumulated evidence has suggested that 
neurons undergo cell death post-cell cycle progression in neurodegenerative diseases. 
For example, G1 -S progression neuronal apoptosis in female rats (Lin et a l ,  2001), S 
phase transition in Alzheimer’s diseased brain (Bonda et a l ,  2009), and G2-M 
hansition in the Alzheimer’s disease brain (Scaife, 2004) have all been reported. Cell 
cycle phase transition has also been found to be consistent with the expression of 
regulatory markers such as cyclin B, E, CDK2 and cyclin D1 (Nagy et a l ,  1997). 
These findings suggest that neurons under stress may complete G1 and S phase and 
enter G2 phase. Our results agree with these findings and suggest a strong role of the 
cell cycle in L-glutamate-induced HT-22 cell death.
HT-22 cells are immortalised cells that proliferate under normal cell growing 
conditions, It is reasonable to assume that these cells exhibit normal cell cycle 
profiles when growing in stress-free conditions, which thus enables the study of the 
cell cycle under L-glutamate-induced stress conditions. Although possible that 
oxidative stress may activate cell cycle re-entry, a number of reports have shown that 
ROS cause cell cycle aiTest (Shackelford et a l ,  2000, Sahu et a l ,  2009, Burhans and 
Heintz, 2009). For example, seizure of the cell cycle in G2/M phase has been 
observed in the PC12 neuron cell line in response of ROS (Wu et a l ,  2010). In 
fibroblast-derived L929 cells, rapid ROS generation also induced cell cycle anest in 
G2/M phase (Thayyullathil et a l ,  2008). In the latter case, cell cycle arrest was due 
to early accumulation of P53 and P21 as a result of ROS insult. However, in this 
study L-glutamate treatment did not arrest or delay the cell cycle in HT-22 cells at
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any time point until cell death occured. This may be because L-glutamate-induced 
oxidative stress does not activate P53 in HT-22 cells (Chapter 3).
To study the effect of L-glutamate on the regulation of HT-22 cell cycle, two 
approches were used to arrest the cell cycle at specific points. The first approach, 
using serum starvation arrested cells in the GO/Gl phase; an effect that was not 
reversed by L-glutamate treatment. However, the HT-22 cells survived L-glutamate- 
induced cell stess when they were maintained in low serum medium. The second 
approach blocked the cell cycle in G2/M phase by using Nocodzol as a cell cycle 
inhibiting agent. Likewise, the cells arrested in G2/M did not die in response to L- 
glutamate treatment when Nocodozol was present. Further confirmation that re-entry 
to the cell cyle is involved in L-glutamate-induced cell death came from the fact that 
L-glutamate only caused cell death once the cycle was allowed to progress, by 
removal of the inhibitory conditions. These findings causally link the cell cycle to L- 
glutamate-induced cell death.
Inhibition of JNK has been shown to provide protection against neuronal cell death
stimuli in primary cultures o f hippocampal neurons (Munay et a/., 1998), slice
culture of hippocampal neurons (Runden et a l ,  1998), PC-12 cells, rat cerebellar
granule cells (Scaife, 2004), and HT-22 hippocampal cells (Suh et al ,  2007). In
agreement with the previous studies, the JNK inliibitor used herein promoted HT-22
cell survival against L-glutamate insults. JNK inhibition also resulted in HT-22 cell
cycle arrest at the G2/M phase. It is been reported that JNK inhibition interrupts the
cell cycle through interaction with cell cycle regulators such as cyclins, cyclin-
dependent kinases and their inhibitory proteins such as p21 and p38 (Scaife, 2004,
Suh et al ,  2007). The other possibility is that JNK interacts with and/or promotes
microtubule assembly, thereby causing cell aiTest at G2/M phase (Huang et al ,
_
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2004). The JNK inhibitor caused cell cycle aiTest in normal HT-22 cells, which 
indicates a possible role o f JNK in basal cell cycle G2/M phase progression. Indeed, 
it has been reported that JNK enliances microtubule associated protein 2 activity in 
hippocampal cells (Chang et al ,  2003).
Despite the fact that stress-induced apoptosis mediated by JNK is linlced to 
cytochrome C release and caspase activation (Kuan et al ,  2003), this mechanism 
does not apply in L-glutamate-induced HT-22 cell death due to the lack of  
cytochrome C release and caspase activation in this cell line (Elphick et a l ,  2008). 
Moreover, L-glutamate-induced oxidative stress did not induce p21 in HT-22 cells 
while it is been reported that JNK inhibition by curcumin in HT-22 induces both P21 
and Cyclin D1 (Suh et al ,  2007). That the JNK inhibitor prevented neither 
mitochondrial ROS nor general ROS elevation, suggests that L-glutamate-induced 
oxidative stress is not the only cause of cell death. This data also suggests that the 
protective effects of the JNK inhibitor can be attributed to the cell cycle inliibition 
rather than the inhibition of oxidative stress.
The results of the cyclohexamide experiment also confirmed the role of MAP kinases 
and entrance to the cell cycle in L-glutamate-induced HT-22 cytotoxicity. 
Cyclohexamide can protect cells by several different mechanisms including 
enhancing glutatliione synthesis (Castagne and Clarke, 1997), decreasing P53 levels 
(Bai and Cederbaum, 2006), activating caspase-3 and suppressing Poly ADP-Ribose 
polymerase (PARPl) cleavage (Gangadliar et al ,  2008). In agreement with these 
previous studies, CHX prevented intracellular ROS accumulation and also 
specifically abolished mitochondrial ROS elevations. The antioxidant properties of 
CHX are likely to have come from its ability to inhibit the protein synthesis,
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ultimately shunting cysteine from protein synthesis to glutathione assembly and the 
elevation antioxidant enzyme activity. CHX has also been found to prevent the 
synthesis of an upstream regulator of JNK, to disrupt cell spindle formation and to 
decrease cdc2/cyclin B kinase and MAP kinase activities (Chang et al ,  2003, 
Gangadliar et a l ,  2008). Hence, it is reasonable to propose that cell cycle arrest can 
be included in the protective effects of CHX.
5.5 Conclusion
In conclusion, L-glutamate-induced HT-22 cell death was completely prevented by 
arresting the cell cycle even in presence of high levels of ROS. In addition, the 
results o f this study indicate that the failure to control L-glutamate-treated HT-22 cell 
cycle and cell cycle progression are strongly linlced to L-glutamate-induced HT-22 
cell death.
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6 Chapter 6: The proposed model of L-glutamate-induced toxicity in 
HT-22 ceil Une
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6A The proposed model o f  glutamate-induced HT22 cell death
Glutamate, a major excitatory neurotransmitter in the CNS, plays a critical role in 
neurological disorders. However, an alternative non-receptor mediated oxidative 
neurotoxic pathway has also been described in immature primary neurons and in 
oligodendi'oglia (Muiphy and Baraban, 1990, Yoshioka et al,  2000). In this study, the 
HT-22 mouse hippocampal cells line, which is characterised by a lack of glutamate 
receptors was used to investigate the molecular mechanisms behind non-receptor 
mediated cell death pathways induced by glutamate. Figure 6.1 outlines the model of 
glutamate-induced toxicity in HT-22 cells as found by this study.Glutamate-induced 
HT22 cell death is initiated through blocking or reversing of the cystine/L-glutamate 
exchanger, resulting in depletion of intracellular GSH and rendering the cell susceptible 
to ROS-induced damage, ultimately leading to oxidative cell death. In agreement with 
earlier studies (Tan et al ,  1998a, Noh et al ,  2006 and Ha and Park, 2006), L- 
glutamate induced time-dependent HT22 cell death in parallel with increased 
ROS production. The antioxidant NAC completely prevented the increase in ROS 
formation caused by L-glutamate and rescued HT22 cells providing further evidence of 
the importance of ROS in initiating the cascades of events leading to glutamate-induced 
HT22 cell death. However, this study investigated whether other mechanisms may be 
involved in glutamate-induced HT22 cell death.
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Figure 6.1 Proposed model of glutamate-induced toxicity in HT-22 cells.
Upon exposure to high levels o f glutamate the cysteine/glutamate transporter is reversed or blocked, resulting in 
depletion o f GSH levels. A build up o f ROS initiates cascade o f events in HT-22 cells including activation o f cell 
death via caspase-independent pathway, mitochondrial dysfunction and cell cycle progression. These effects are 
reversed by the use o f the different conpounds listed to the left.
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The types of death in glutamate-induced HT22 cell injury were investigated to clarify 
whether it was apoptosis, necrosis or a new form of cell death. However, in agieement 
with previous work in this laboratoiy, this study shows that the HT22 cells die via a 
form of programmed cell death that is similar to, but distinct from, classical apoptosis 
and necrosis. It is characterised by cell and nuclear shrinkage and clii'omatin 
condensation, yet occurred in the absence of membrane asymmetry, DNA 
fragmentation, mitochondrial cytochrome c release, or caspase activation. Earlier studies 
showed that the protective effects of Nec-1 in HT-22 cells involved an increase in 
cellular GSH levels as well as a reduction in ROS production (Xu et al ,  2007). 
However, Nec-1 did not protect HT-22 cells against hydrogen peroxide induced cell 
death, suggesting that Nec-1 has no antioxidant effects in these cells. In addition, Nec-1 
has been shown to rescue HT-22 cells even when cellular GSH was depleted (Xu et al ,  
2007). The protective effect of Nec-1 has recently been reported to be mediated by its 
ability to block the kinase activity of receptor interacting protein 1 (RIPl), which is an 
essential component of the necroptosis pathway (Degterev et al ,  2008, Vandenabeele et 
al,  2010b, Zhu et al ,  2011). In further studies, inhibition of RIPl activity via Nec-1 
efficiently inliibited necroptosis in an immortalised stiatal cell line (ST 14A) and in an 
R6/2 transgenic mouse model of Huntington's disease (Zhu et al ,  2011). These reports 
provide support to the premise that Nec-1 mediated its protective effect on HT-22 cells 
via inhibition of fundamental components in the necroptosis pathway.
An increase in Ca^  ^levels in HT-22 cells exposed to L-glutamate has been previously 
documented (Herrera et al,  2007, Tan et al ,  1998a). Previous experiments in our_
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laboratory have shown that in the absence of extracellular Ca^ ,^ L-glutamate-induced 
HT-22 cell death is significantly suppressed (Elphick et al ,  2008). The results presented 
here show that chelating intiacellular Ca^  ^prevents both ROS formation and cell death 
in glutamate-treated HT-22 cells. This suggests that an increase in the intracellular Ca^  ^
levels is not only responsible for glutamate-induced cell death (Elphick et al ,  2008), but 
it is also involved as a ROS-generator. In support of this model, the role of extiacelluar 
Ca^  ^influx has been previously reported to cause an increase in ROS in HT-22 cells (Ha 
and Park, 2006).
MPT pores have been found to play an important physiological role in helping the 
mitochondria to buffer intracellular Ca^ "^ , which is a determining factor in neuronal 
death (Azarashvili et al ,  2010). On the other hand, ROS generation promotes Ca^  ^
release and therefore enhances the probability of MPT pore opening. The data presented 
in this research strongly suggest that Ca^  ^influx, intracellular Ca^ ,^ and MPT pores all 
play a role in ROS production and glutamate-induced cell death. Furthermore, 
preventing ROS formation by blocking or chelating Ca^  ^indicates that GSH depletion is 
not the only the cause of intracellular ROS elevation in HT -22 cells.
Glutamate-treated HT-22 cells show to undergo significant dose-dependant decreases in 
AT^ m. This indicates that AYm collapse is involved in glutamate-induced HT-22 cell 
death. These observations, combined with the previous observations that glutamate 
induces ROS in a dose-dependant manner, could reflect a coiTclation between degree of 
ATm reduction and ROS levels in the cells, which ultimately causes cell death. Under 
oxidative stress conditions, the A'Fm collapse occurs due to the opening of MPT pores 
(Rosenstock et al ,  2004, Trushina and McMurray, 2007, Kass et al ,  1992). Protection
_
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from glutamate-induced cell death of HT-22 cells by CsA (an MPT pore inhibitor) seen 
in this study suggests that the MPT pores are important in the cell death pathway 
activated by glutamate.
Cell cycle data in this study reveals that the cell proliferation in HT-22 cells is 
intimately linked to a process of cell death. The role of cell cycle in the cell death 
pathway activated by glutamate has been shown through two approaches to arrest the 
cell cycle at specific points. The first approach was tlrrough using semm starvation 
which aiTests HT-22 cells in the GO/Gl phase; under these condetions the HT-22 
survived glutamate-induced cell stress when they were maintained in low serum 
medium. The second approach was by blocking the cell cycle in G2/M phase by using 
Nocodzol as a cell cycle inhibiting agent. Likewise, the cells arrested in G2/M did not 
die in response to glutamate treatment when Nocodozol present. Further confirmation 
that re-entry to the cell cycle is involved in glutamate-induced cell death came fiom the 
observation that glutamate only caused cell death once the cycle was allowed to 
progress, by removal of the inliibitory conditions. These findings causally link the cell 
cycle to glutamate-induced cell death in HT-22.
Cyclohexamide experiments also confirmed the role of entrance to the cell cycle in 
glutamate-induced HT-22 cytotoxicity. CHX can protect cells by several different 
mechanisms including enhancing glutathione synthesis (Castagne and Clarke, 1997), 
decreasing P53 levels (Bai and Cederbaum, 2006), activating caspase-3 and suppressing 
Poly ADP-Ribose polymerase (PARPl) cleavage (Gangadliar et ai ,  2008). In agreement 
with these previous studies, CHX prevented intracellular ROS accumulation and also 
specifically abolished mitochondrial ROS elevation. The antioxidant properties of CHX
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are likely to have come from its ability to inhibit protein synthesis,ultimately shunting 
cysteine from protein synthesis to glutathione assembly and the elevation antioxidant 
enzyme activity. CHX has also been found to prevent the synthesis of an upstream 
regulator of JNK, to dismpt cell spindle formation and to decrease cdc2/cyclin B kinase 
and MAP kinase activities (Chang et al ,  2003, Gangadhar et al ,  2008). Hence, it is 
reasonable to propose that cell cycle anest can be included in the protective effects of 
CHX.
Interestingly, blocking the cell cycle in glutamate -treated HT-22 cells using JNK 
inhibitor rescued the cells despite elevation of both intracellular ROS and mtROS. 
Inhibition of JNK has been shown to provide protection against glutamate-induced 
neuronal cell death in HT-22 hippocampal cells through cell cycle arrest at the G2/M 
phase. It is been reported that JNK inhibition inteniipts the cell cycle through interaction 
with cell cycle regulators such as cyclins, cyclin-dependent kinases and their inhibitory 
proteins such as p21 and p38 (Scaife, 2004, Suh et al ,  2007). The other possibility is 
that JNK interacts with and/or promotes microtubule assembly, thereby causing cell 
arrest at G2/M phase (Huang et al., 2004). The JNK inhibitor caused cell cycle arrest in 
normal HT-22 cells, which indicates a possible role of JNK in basal cell cycle G2/M 
phase progression. Indeed, it has been reported that JNK enhances microtubule 
associated protein 2 activity in hippocampal cells (Chang et al ,  2003). However, JNK 
inhibition increased the ROS formation in presence of glutamate therefore It would 
appear that the protective effects of the JNK inhibitor observed previously are not 
mediated via prevention of ROS production and strongly suggests the role o f cell cycle 
in glutamate-induced cells death.
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6,2 The application o f this study
This study highlights the importance of including the whole picture of receptor- 
independent glutamate-induced neui onal cell death when considering treatment avenues 
for neurodegenerative diseases by supplying new targets for drug therapy. There may be 
different types of cell death that neurons undergo depending on the insult intensity and 
the degree of injury, e.g. following ischaemia the neurons undergo necrotic cell death in 
the core of the lesion, where most of the cells suffer severe hypoxia, while apoptosis 
occurs in the area where blood flow reduces the severity of hypoxia insults (Charriaut- 
Marlangue et al ,  1996, Linnik et al ,  1993). Therefore, the application of caspase 
inhibitors, although limiting the apoptotic may exacerbate oxidative toxicities according 
to these study results.
Moreover the stability of the necrosome complex which is fundamental components in 
the necroptosis death pathway depends on the existence of caspase inhibitors (Feng et 
al,  2007, He et al ,  2009). Hence targeting the death associated molecules such as RIPl, 
RIP3, and proteases other than caspases limit glutamate-induced cell death.
On the other hand, a substantial body of evidence links the failure of cell cycle 
regulation in post-mitotic neurons to neuronal cell death pathways that lead to several 
neurodegenerative disorders (Greene et al ,  2007, Majd et al ,  2008). This study shows 
that failure of cell cycle regulation might be a root cause of glutamate-induced neuronal 
cell death through the receptor-independent pathway. Therefore, targeting the cell cycle 
regulators may stop neuronal cell death.
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6.3 Future work
This study proposes that glutamate-induced HT-22 cell death may follow necroptosis 
pathway. One direction of future work is to identify other key molecules that regulate 
the necroptosis pathway such as poly (ADP-ribose) polymerase 1 (PARP-1), 
cyclophilin D, lysosomal membrane permeabilisation (LMP) in neurons.
The HT-22 model used in this study shows that the failure of cell cycle regulation might 
be a root cause of glutamate-induced neuronal cell death through the receptor- 
independent pathway. Futui'e work shall explore cyclins and their gene signatures that 
can serve to progress the cell cycle in HT-22 cells due to glutamate treatment.
This study investigated the biochemical pathways associated with glutamate-induced 
cell death using HT-22 immortalised cell lines as a valuable tool in understanding 
molecular and cellular processes relevant to glutamate-induced hippocampal injury. 
Future work will be necessary to examine whether this study observations are 
reproducible with primary neuronal culture and in vivo study.
6.4 Conclusions
HT-22 cells died via a form of programmed cell death that is similar to, but distinct 
from, classical apoptosis and necrosis. This cell deaüi is characterised by cell shiinlcage, 
yet occurs in the absence of membrane asymmetiy, DNA fragmentation, mitochondrial 
cytochrome C release, and caspase activation. This study provides support to the 
premise that glutamate-induced cell death occurs via necroptosis pathway.
150
C h a p t e r  6: T h e  p r o p o s e d  m o d e l  o f  L - g l u t a m a t e - i n d u c e d  t o x i c i t y  i n  HT-22 c e l l  l i n e  
GSH depletion initiate build up of ROS but it is not the only cause of ROS 
accumulation; MPT pores have an important physiological role in glutamate-induced 
HT-22 cell death involving mtROS production and AYm depletion.
Glutamate-induced HT-22 toxicity is depends on cell cycle progression that might be a 
root cause of glutamate-induced neuronal cell death thr ough the receptor-independent 
pathway.
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